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ABSTRACT

CHARACTERIZATION AND PHYSICOCHEMICAL MODIFICATIONS OF
POLYMER HOLLOW FIBER MEMBRANES FOR BIOMEDICAL
AND BIOPROCESSING APPLICATIONS

by

Benjamin R. Madsen, Doctor of Philosophy
Utah State University, 2010

Major Professor: Dr. David W. Britt
Department: Biological and Irrigational Engineering

Hollow fiber membranes (HFMs) formed through phase inversion methods
exhibit specific physicochemical characteristics and generally favorable surface and
mechanical properties, supporting their use in diverse applications including
ultrafiltration, dialysis, cell culture, bioreactors, and tissue engineering. Characterization
of, and modifications to, such membranes are important steps in achieving desired
characteristics for specific applications.
HFMs subject to gas, irradiation, and chemical sterilization techniques were
characterized based on several analytical techniques. It was revealed that these common
sterilization techniques can cause inadvertent changes to HFM properties. While these
changes may cause detrimental effects to HFMs used in filtration, the methods of
sterilization are also presented as a facile means of tuning properties toward specific
applications.
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Modifications to HFM surface chemistries were also sought as a method of
adsorbing bacterial lipopolysaccharide (LPS) from solutions used in hemodialysis
treatments and bioprocessing applications.

It was found that additives such as

polyvinylpyrrolidone (PVP), polyethyleneglycol (PEG), and poly-L-lysine (PLL) can
facilitate adsorption capacities of HFMs toward LPS. Additionally, chemical changes are
presented as a means of preferentially adsorbing LPS to specific locations on the HFM
surface.
(161 Pages)
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CHAPTER 1
INTRODUCTION
ESRD AND DIALYSIS
Chronic renal failure (end stage renal disease, ESRD) is the final pathway of
several kidney diseases. The choices for a patient that has reached the point where renal
function is no longer sufficient to sustain life are 1) chronic dialysis treatment
(hemodialysis, peritoneal dialysis), 2) renal transplantation, or 3) death. In 2006, more
than 506,000 people in the United States suffered from ESRD, while 327,000 patients
were receiving chronic hemodialysis. The costs of Medicare spending on ESRD in 2006
were $23 billion (6.4% of total Medicare budget), while $17 billion was spent on dialysis
alone (1). ESRD research, then, is of great importance to both the economy and society
in general.
ESRD is the final stage of chronic kidney disease (CKD). CKD is defined as
either kidney damage or decreased kidney function for 3 or more months (2). There are
several factors that either cause susceptibility to or direct initiation of CKD.
Susceptibility factors include age, family history, reduction in kidney mass, low birth
weight, racial or ethnic minority status, and low income status (3). Initiation factors
include diabetes, high blood pressure, autoimmune diseases, systemic infections, urinary
tract infections, and urinary stones (3).
There are several markers currently used to diagnose reduced kidney function
including persistent proteinuria, abnormalities in urine sediment, blood and urine
chemistry measurements, abnormal findings on imaging studies, and decreased
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glomerular filtration rate (GFR) (2, 4). Of these, GFR is considered the most accurate
method of determining kidney function (5). Kidney failure, or stage 5 CKD, occurs when
the GFR of the kidney is less than 15 ml/min per 1.73 m2 (3). Normal GFR for a young
adult is approximately 120-130 ml/min per 1.73 m2, however, GFR levels are largely
dependent on age, sex, and body size (5-6).
While kidneys are generally known as the filters of the body, they have many
other functions such as regulating the circulation of blood volume through hormonal
control of red blood cell mass, directly controlling salt and water excretion, regulating
bone mineralization through calcium and phosphorus excretion and Vitamin D synthesis,
and controlling the acid-base balance in the body, plasma tonicity, potassium levels, and
blood pressure (7-8). Dialysis, which filters blood by transport of toxins through a
membrane, is very limited in its ability to mimic the kidney. Thus, the ideal solution to
kidney failure is kidney transplantation, with dialysis serving as a short-term bridge to
transplantation.
The 2008 Renal Data System annual report (1) showed that in 2006 there were
over 68,000 people in the United States waiting for a kidney or kidney-pancreas
transplant, while only 18,052 transplants were performed. The median wait time for
kidney transplantation was 2.84 years in 2003, with wait time varying by race from 2.3
years for whites, 3.8 years for blacks, and 4.0 years for other races. Four percent of
patients in their first year of waiting for a transplant die, while 28% die who are in their
fifth year of waiting. Therefore, improvements in technology and procedures for those
undergoing dialysis is of vital importance to kidney failure patients.

3
Once kidney function decreases sufficiently to be classified as ESRD, there are
two dialysis possibilities available to a patient:
dialysis (PD).

hemodialysis (HD) and peritoneal

PD involves using the peritoneum (a membrane surrounding the

abdominal cavity) to filter toxins from the blood by filling the peritoneal cavity with a
dialysate solution. Because this method of dialysis can be self-administered it is a more
attractive alternative than HD; however, only about 5% of patients in the U.S. were
undergoing PD in 2006 (1). The reason for this can be attributed to the high dropout rate
for PD due to technique-related problems. Only a limited number of patients stay on PD
over a period of 5 years.

Generally, technique failure is the main cause of either

switching to HD or death, with peritonitis the leading complication (9). Improvements in
materials, dialysate composition, and patient training are needed to covercome the main
causes of PD failure including catheter infection, peritoneal sclerosis, and neoplasm of
the gastrointestinal tract (10-11).
HD treatment is performed on approximately 65% of ESRD patients (the
remaining 35% of those with ESRD are prevalent transplant patients or PD patients) (1).
HD is the process by which blood is filtered extracorporeally by passing it through a
semipermeable membrane, whereupon toxins in the blood are removed (Fig. 1.1).
Thousands of hollow fibers are contained in a housing and together they comprise a
dialyzer. A solution is passed on the outside of the fibers countercurrent to the blood,
providing conditions necessary for cleaning the blood.
Dialysis is generally governed by three principles: diffusion, ultrafiltration, and
convection (12). Diffusion refers to the movement of small molecular weight species,
including electrolytes, across the dialyzer membrane. Ultrafiltration (UF) involves the
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A

Dialysate out

Dialysate in

Dialyzer
Blood from
patient

Cleaned blood
returning to
patient

Dialysate
flow

B
Blood flow

FIG. 1.1. Diagram of hemodialysis procedure. (A) Blood is removed from a patient and
filtered through a dialyzer, then returned to the body. (B) Blood is passed through the
inside of a hollow fiber membrane while dialysate flows countercurrent on the outside.
movement of water across the semipermeable membrane through the use of external
pressure and is the primary method for water removal from the blood.

With the

movement of solvent molecules, larger molecules are transported by convection. Ideally,
smaller molecules, such as sodium and potassium, can pass through the membrane easily
due to diffusion. However, larger molecular weight species, such as human serum
albumin (HSA), are limited based on the molecular weight cutoff of the dialyzer despite
the convective forces.
Dialysate, the solution passed on the outside of the hollow fibers is a fluid
composed of electrolytes, dextrose, and water with exact chemistries dependent on the
needs of the dialysis patient (13).

Recently there has been a trend toward using

bicarbonate dialysate in conjunction with high-flux dialyzers (14). Bicarbonate dialysate
has been shown to improve patient nutritional status accompanied by an increase in
serum bicarbonate levels, which results in a decreased frequency of acidosis (15-16).
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Credit for the first human dialysis treatment is generally ascribed to Georg Haas
who treated an acute renal failure patient in 1924, but the process was further refined with
more suitable conditions by Willem Kolff in the 1930‟s and 1940‟s (12).

Further

improvements in HD treatment sought to make the hollow fiber membrane more
biocompatible, as well as improve the materials used in membrane manufacture.
Cellulose membranes, because of their ease in manufacturing and excellent diffusivity
and mechanical properties, were first used as dialysis membanes, but the introduction of
synthetic membranes formed from polysulfone (PS) and polyacrylonitrile (PAN) caused a
change in the dialysis community. PS membranes offered the ability to control molecular
weight cutoff, improved biocompatibility, and the choice of steam-sterilization (17).
Researchers today are focusing on improving the quality of life of patients, the costeffectiveness of treatment, and the mortality rate of ESRD patients, which remains higher
than that of the general population.
BIOPROCESSING
The ability to produce human proteins using genetic engineering rather than
isolating them from tissue samples has become an important technology in therapeutic
medicine. Since the first E. coli bacteria were infused with recombinant DNA to produce
human insulin, over 100 other drug substances have been produced using recombinant
technology. As this field expands, improvements in downstream processing to isolate a
wider range of recombinant therapeutics from a wider range of cell types will be
necessary.

6
Genetic engineering of cells involves the transplantation of a gene via a vector to
a new host organism. The term transfection (transformation via infection) is often used
to describe this process. This transfer of DNA is accomplished through one of several
established techniques.

Transfection by calcium phosphate involves precipitation of

DNA, which is then added to the cells to be transfected. The complexed DNA is then
taken up by the cells and incorporated in the genome (18).

A method gaining in

popularity is that of polymer-based gene delivery wherein plasmid DNA and cationic
lipids or polymers such as polyethylenimine (PEI) or diethylaminoethylene-dextran
(DEAE-dextran) form a complex which is then taken up by a cell. Uptake pathways are
dependent on the polymer and cell type used (19). Incorporation of DNA fragments into
liposomes has been shown to be very effective with mammalian cells (20).
Upon transfection, the host cell proliferates and produces the desired recombinant
protein given the right conditions. While the first cell lines used to produce human
proteins were often bacterial strains (most predominantly E. coli), transfection of
eukaryotic cells was shown to be necessary in certain cases due to the need of
glycosylation, wherein sugar moieties are added to the protein post-translational. Four
eukaryotic cell lines are generally used: S. cerevisiea, Chinese hamster ovary (CHO),
baby hamster (BHK), and human fibrosarcoma cells. It has been shown, however, that
not all eukaryotic cells perform this step identically as yeast cells often yield different
glycosylation patterns than mammalian cells. Metabolically engineered plant cells are
also being investigated to produce human-like sugar moieties on proteins (21).
While glycosylation is necessary to produce some proteins, other proteins have
been shown to be functional despite the lack of this step. E. coli cells are now capable of
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producing functional therapeutic proteins such as interferon-α (IFN-α), IFN-β, IFN-γ,
tissue necrosis factor-α (TNF-α), and interleukin-2. Yeast cells are often used to produce
human insulin, glucagons, and several blood anticoagulant factors. It must be noted that
some „artificial proteins‟ have been shown to perform better than their „natural protein‟
counterparts, as is the case with IFN-β-1b (21).
Production scale-up of protein production will not be discussed here. This is a
very sensitive process wherein proper levels of nutrients and mixing conditions must be
maintained to maximize production and minimize metabolic overload on cells.
Harvesting of proteins from cell cultures is also a complex subject which will be
mentioned only briefly. Mammalian cells tend to secrete recombinant proteins, whereas
bacteria usually sequester them (often in inclusion bodies) within the cell in a denatured
state (21-22). Because the proteins are denatured, post-production modifications must
take place to activate the protein. Downstream processing, specifically the removal of
bacterial cell wall fragments, will be discussed in Chapter 2.
Mammalian cells represent the best option for producing viable human proteins.
However, due to high costs of fermentation and high safety costs of working with
mammalian cells, bacterial and yeast cell lines are more attractive. Continuing research
is being done in the field of bioprocessing to lower overall costs and to produce other
valuable proteins.

8
BACTERIA
Endotoxin
Of constant importance to both the dialysis and bioprocessing communities is the
issue of bacterial endotoxin (lipopolysaccharide, LPS) that exists on the outer membrane
of gram-negative bacteria. LPS is firmly anchored within and can constitute up to 75%
of the cell outer membrane (Fig. 1.2) (23-24). It is responsible for organization and
stability, although it is also important in interactions with other cells and proteins (24).
Removing LPS from solution is necessary because there exist up to two million LPS
molecules per bacterium (25).

FIG. 1.2. Diagram representing the outer cell wall of gram-negative bacteria. LPS
molecules in the outer membrane are represented with lipid A anchored in the
phopholipid bilayer and core and oligosaccharide chains extending into the extracellular
space.
LPS consists of three main parts: an outer-membrane-integrated lipid (Lipid A), a
core oligosaccharide, and a long heteropolysaccharide chain (O-antigen) (25). The Oantigen, consisting of a chain of repeating oligosaccharide units (3-8 monosaccharides),
varies among different bacterial strains and is the recognition site for blood-borne
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antibodies. The lipid A portion is generally conserved among bacterial types and is
responsible for eliciting pyrogenic reactions.

A schematic view of a typical LPS

monomer is depicted in Fig. 1.3.

FIG. 1.3. Schematic view of the chemical structure of endotoxin from E. coli O111:B4
(26). Hep, L-glycero-D-manno-heptose; Gal, galactose; Glc, Glucose; KDO, 2-keto-3deoxyoctonic acid; NGa, N-acetyl-galactosamine; NGc, N-acetyl-glucosamine. This
research was originally published in the Journal of Biological Chemistry. Ohno N,
Morrison DC. Lipopolysaccharide interaction with lysozyme. J Biol Chem. 1989;
264:4434-41. © the American Society for Biochemistry and Molecular Biology.
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The lipid A consists of a phosphorylated N-acetyl-glucosamine (NAG) dimer,
connected to typically 6 or 7 saturated fatty acid chains (26-27). The variability of the
fatty acid chains plays an important role in determining toxic properties, resisting host
antimicrobial factors, and avoiding recognition from specific components of the host
immune system (28-30).

The hydrophobic nature of lipid A allows attachment to

hydrophobic surfaces (25). Also of importance are the phosphate groups on the lipid A
and core saccharide regions, facilitating adsorption to surfaces through ionic interactions
(25).
The size of LPS varies from monomers of 10 kDa, to micelles of 1000 kDa or
larger (25, 31-32). The predominant form of LPS in solution is as aggregates in the form
of micelles and vesicles. Several methods of analyzing LPS aggregates have been used
including atomic force microscopy (AFM), steady-state fluorescence, dynamic light
scattering, NMR diffusometry, and cryo-tunneling electron microscopy (TEM) (33-35).
Aggregates has been reported to exist at concentrations from 10 μg/ml up to 300 μg/ml
with an average micelle size of approximately 19 nm and larger aggregates up to 320 nm
(33). The supramolecular structure has been described as in Fig. 1.4. These micelles and
vesicles vary in size and stability depending on solution pH and concentration of any
detergents or ions (25, 32, 35). It has also been described that LPS monomers can be
released from micelles through the use of certain proteins (36).
LPS at concentrations as low as 4 ng/kg body weight are capable of eliciting a pyrogenic
response in adults, however, critical concentrations depend on the virulence of the
organism, the infection site, the host response, and some genetic factors (25, 37).
Pyrogenic response can include fever, shivering, hypotension, adult respiratory distress
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syndrome, disseminated intravascular coagulation, endotoxin shock, or death (25).
Contrary to popular belief, endotoxin does not attack host cells directly but rather the
pyrogenic response is a result of the host immune system reacting to the presence of LPS.
LPS has been reported to activate the complement, coagulation, and kinin systems,
although the exact method of recognition has only recently been discovered (25). Upon
entrance into the blood stream LPS binds to LPS-binding protein (LBP). This complex
then binds to a soluble receptor protein, CD14, which in turn binds to Toll-like receptor-4
(TLR-4), found on monocytes, inducing signal transduction. The monocytes then release
pro-inflammatory cytokines such as interleukin-1 (IL-1), IL-6, and (TNF-α).

FIG. 1.4. Structures of LPS aggregates in aqueous solutions. An LPS monomer is
depicted on the left with lipid A (black rod), phosphate groups (black circles), and
saccharide group (white rod). Bivalent cations (white circles) facilitate formation of
micelles and vesicles. (Reprinted from Journal of Biotechnology, 76, Petsch D, Anspach
FB, Endotoxin removal from protein solutions, 97-119, Copyright (2000), with
permission from Elsevier (35).
Bacteria in solutions
Because minute traces of bacteria or LPS can cause adverse immune system
reactions, it is important to prevent any possible contamination of water sources in
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dialysate and remove any LPS contamination when isolating recombinant proteins from
gram-negative bacteria.
The most sensitive technique to measure LPS concentrations in solution is the
limulus amebocyte lysate (LAL) assay. This assay is based on the coagulation of cell
lysate of the horseshoe crab Limulus polyphemus in contact with very low concentrations
of LPS. LPS concentrations measured with this test are generally reported in endotoxin
units (EU) per ml, where one EU is equivalent to 0.1 ng of LAL reactivity of the U.S.
Pharmacopoeia reference standard endotoxin, EC-5 from E. coli 0113:h10:K (38).
Bacterial contamination in dialysate fluids and clinical water sources has been
documented (39-42). A diverse community of culturable bacteria has been found in
dialysate fluids, of which Pseudomonas is most common (43-46).

Robust, sessile

bacterial communities, called biofilms, may present a persistent source of contamination
in dialysate water production lines because they are difficult to detect and remove (4042). Several studies on water and dialysate quality in clinics in the U.S. and Europe have
shown that as many as 20% of the samples tested were above the limit of the
recommended standards (45, 47-48). While small quantities of contamination may not
always elicit a pyrogenic response, continued exposure to contaminated dialysate is of
great concern because a typical patient on hemodialysis therapy will be directly exposed
to 18,000-30,000 liters of water annually (46, 49). Reported pyrogenic reactions up to
0.7 per 1000 treatments have been reported (14, 46, 50).
LPS contamination is prevalent in other sources besides that of water used in
dialysate. Tap and mineral water have been reported to contain 1-20 EU/ml, while water
in an open-air swimming pool contained over 25,000 EU/ml (51). Ingestion of LPS
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poses little risk as compared to direct introduction into the blood, as in dialysis, or
injection of contaminated recombinant therapeutics. Still a higher possibility of LPS
contamination exists in solutions prepared from gram-negative bacteria. A solution of
proteins from high cell density cultures of E. coli contained over 2 million EU/ml, while
proteins from shaking flask cultures of E. coli contained 70,000-500,000 EU/ml (35).
Commercial preparations of bovine serum albumin (BSA) contained up to 50 EU/ml
(35).
RESEARCH OBJECTIVES
The research is driven by the following hypothesis: “Hollow fiber membranes
exhibit properties favorable to secondary functionality, such as endotoxin removal,
during primary application in dialysis or isolation of therapeutics from recombinant
bacteria.”
To test this hypothesis, a series of experiments were designed to explore
physicochemical characteristics of HFMs undergoing several sterilization procedures.
Also, chemical modifications to hollow fibers were explored based on the theory that
membrane surface chemistry can act as an endotoxin adsorption matrix in both dialysis
and filtration applications. To achieve these goals, the experimental work of this research
was divided into three specific aims:
1. Effect of sterilization techniques on physicochemical properties of polysulfone
hollow fibers. Polysulfone hollow fibers subjected to ethylene oxide, bleach and
electron-beam sterilization treatments were characterized to deduce the overall
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effects to surface hydrophilicity, surface morphology, and membrane sorption
abilities.
2. Hemodialysis membrane surface chemistry as a barrier to endotoxin transfer.
Membrane surface chemistry, more specifically polyvinylpyrrolidone content in
the polymer structure, was investigated as a mechanism to adsorb bacterial
endotoxin and prevent possible back-filtration in hemodialysis conditions.
3. Hollow fiber membranes modified with poly-L-lysine as endotoxin scavengers.
The addition of poly-L-lysine to polysulfone hollow fiber membranes was
investigated as a potential tool for scavenging endotoxin from both dialysate
solutions and biological solutions prepared from gram-negative bacterial cultures.
Interactions of poly-L-lysine and endotoxin were investigated using several
analytical techniques.
Chapter 2 will discuss current research being done on hollow fiber membranes
including material choice, membrane analysis techniques, and cleaning of membranes.
Another section will discuss current techniques of removing LPS from solutions
including using hollow fiber membranes. The following three chapters will present new
research as per the three objectives outlined above. The final chapter will include general
conclusions and recommendations for further research.
REFERENCES
1.

U.S. Renal Data System, USRDS 2008 Annual Report: Atlas of chronic kidney
disease and end-stage renal disease in the United States, Bethesda, MD: National
Institutes of Health, National Institute of Diabetes and Digestive and Kidney
Diseases, 2008.

2.

15
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National
kidney foundation practice guidelines for chronic kidney disease: Evaluation,
classification, and stratification. Ann Intern Med 2003;139:137-47.

3.

K/DOQI clinical practice guidelines for chornic kidney disease: evaluation,
classification, and stratification. Kidney disease outcome quality initiative. Am J
Kidney Dis 2002;39:S1-246.

4.

Keane W, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection,
elimination (PARADE): A position paper of the National Kidney Foundation. Am
J Kidney Dis 1999;33:1004-10.

5.

Smith HW. Comparative physiology of the kidney. In: Smith HW, ed. The
Kidney: Structure and Function in Health and Disease. New York: Oxford
University Press, 1951:520-74.

6.

Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on
creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol
1976;31:155-63.

7.

Fissell WH, Fleischman AJ, Humes HD, Roy S. Development of continuous
implantable renal replacement:
Past and future. Translational Research
2007;150:327-36.

8.

Hamilton RW. Principles of dialysis: Diffusion, convection and dialysis
machines. In: Henrich WL, Bennet WM, eds. Atlas of diseases of the kidney.
Philadelphia: Blackwell Science, 1999:1.1-1.6.

9.

Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis
and its impact on patient survival. Perit Dial Int 1997;17:360-4.

10.

Augustine T, Brown PW, Davies SD, Summers AM, Wilkie ME. Encapsulating
peritoneal sclerosis: Clinical significance and implications. Nephron Clin Pract
2009;111:c149-c54.

11.

Nodaira Y, Ikeda N, Watanabe K, Inoue T, Gen S, Kanno Y, et al. Risk factors
and cause of removal of peritoneal dialysis catheter in patients on continuous
ambulatory peritoneal dialysis. Adv Perit Dial 2008;24:65-8.

12.

Rosner MH. Hemodialysis for the non-nephrologist. Southern Med J
2005;98:785-91.

13.

Palmer BF. Dialysate composition in hemodialysis and peritoneal dialysis. In:
Henrich WL, Bennet WM, eds. Atlas of Diseases of the Kidney. Philadelphia:
Blackwell Science, 1999:2.1-2.8.

14.

16
Gordon SM, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Aguero SM, et al.
Pyrogenic reactions in patients receiving conventional, high-efficiency, or highflux hemodialysis treatments with bicarbonate dialysate containing high
concentrations of bacteria and endotoxin. J Am Soc Nephrol 1992;2:1436-44.

15.

Williams AJ, Dittmer ID, McArley A, Clarke J. High bicarbonate dialysate in
haemodialysis patients: Effects on acidosis and nutritional status. Nephrol Dial
Transplant 1997;12:2633-7.

16.

Kobrin SM, Raja RM. Effect of varying dialysate bicarbonate concentration on
serum phosphate. ASAIO Trans 1989;35:423-5.

17.

Vienken J, Bowry S. Quo vadis dialysis membrane? Artif Organs 2002;26:152-9.

18.

Graham FL, Eb AJvd. A new technique for the assay of infectivity of human
adenovirus 5 DNA. Virology 1973;52:456-67.

19.

Midoux P, Breuzard G, Gomez JP, Pichon C. Polymer-based gene delivery: A
current review on the uptake and intracellular trafficking of polyplexes. Curr
Gene Ther 2008;8:335-52.

20.

Reisinger H, Sevcsik E, Vorauer-Uhl K, Lohner K, Katinger H, Kunert R. Serumfree transfection of CHO-cells with tailor-made unilamellar vesicles.
Cytotechnology 2007;54:157-68.

21.

Dingermann T. Recombinant therapeutic proteins: Production platforms and
challenges. Biotechnol J 2007;3:90-7.

22.

Graumann K, Premstaller A. Manufacturing of recombinant therapeutic proteins
in microbial systems. Biotechnol J 2006;1:164-86.

23.

Raetz CRH. Biochemistry of endotoxins. Annu Rev Biochem 1990;59:129-70.

24.

Vaara M, Nikaido H. Outer membrane organization. In: Rietschel ET, ed.
Handbook of Endotoxin. Amsterdam: Elsevier, 1984:1-45.

25.

Gorbet MB, Sefton MV. Endotoxin: The uninvited guest. Biomaterials
2005;26:6811-7.

26.

Ohno N, Morrison DC. Lipopolysaccharide interaction with lysozyme. J Biol
Chem 1989;264:4434-41.

27.

Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, et al.
Bacterial endotoxin: Molecular relationships of structure to activity and function.
FASEB J 1994;8:217-25.

28.

17
Bland LA, Oliver JC, Arduino MJ, Oettinger CW, McAllister SK, Favero MS.
Potency of endotoxin from bicarbonate dialysate compared with endotoxins from
Escherichia coli and Shigella flexneri. J Am Soc Nephrol 1994;5:1634-7.

29.

Gunn JS. Bacterial modification of LPS and resistance to antimicrobial peptides. J
Endotoxin Res 2001;7:57-62.

30.

Qureshi N, Kutuzova G, Takayama K, Rice PA, Golenbock TT. Structure of lipid
A and cell activation. J Endotoxin Research 1999;5:147-50.

31.

Yamamoto K-i, Matsuda M, Hayama M, Asutagawa J, Tanaka S, Kohori F, et al.
Evaluation of the activity of endotoxin trapped by a hollow-fiber dialysis
membrane. J Membrane Sci 2006;272:211-6.

32.

Darkow R, Groth T, Albrecht W, Lützow K, Paul D. Functionalized nanoparticles
for endotoxin binding in aqueous solutions. Biomaterials 1999;20:1277-83.

33.

Bergstrand A, Svanberg C, Langton M, Nyden M. Aggregation behavior and size
of lipopolysaccharide from Escherichia coli O55:B5. Colloid Surface B
2006;40:99-106.

34.

Hayama M, Miyasaka T, Mochizuki S, Asahara H, Tsujioka K, Kohori F, et al.
Visualization of distribution of endotoxin trapped in an endotoxin-blocking
filtration membrane. J Membrane Sci 2002;210:45-53.

35.

Petsch D, Anspach FB. Endotoxin removal from protein solutions. J Biotechnol
2000;76:97-119.

36.

Li L, Luo RG. Protein concentration effect on protein-lipopolysaccharide (LPS)
binding and endotoxin removal. Biotechnol Lett 1997;19:135-8.

37.

Dinarello CA, Cannon JG. Cytokine measurement in septic shock. Ann Inter Med
1993;119:853-4.

38.

Tellingen Av, Grooteman MPC, Pronk R, Loon Jv, Vervloet MG, Wee PMt, et al.
Lipopolysaccharide concentrations during superflux dialysis using unfiltered
bicarbonate dialysate. ASAIO J 2002;48:383-8.

39.

Bambauer R, Walther J, Jung WK. Ultrafiltration of dialysis fluid to obtain a
sterile solution during hemodialysis. Blood Purificat 1990;8:309-17.

40.

Hoenich NA, Levin R. The implications of water quality in hemodialysis. Semin
Dialysis 2003;16:492-7.

41.

Man N-K, Degremont A, Darbord J-C, Collet M, Vaillant P. Evidence of bacterial
biofilm in tubing from hydraulic pathway of hemodialysis system. Artif Organs
1998;22:596-600.

42.

18
Marion-Ferey K, Leid JG, Bouvier G, Pasmore M, Husson G, Vilagines R.
Endotoxin level measurement in hemodialysis biofilm using "the whole blood
assay". Artif Organs 2005;29:475-81.

43.

Gomila M, Gasco J, Busquets A, Gil J, Bernaeu R, Buades JM, et al.
Identification of culturable bacteria present in haemodialysis water and fluid.
FEMS Microbiol Ecol 2005;52:101-14.

44.

Tsuchida K, Nakatani T, Sugimura K, Yoshimura R, Matsuyama M, Takemoto Y.
Biological reactions resulting from endotoxin adsorbed on dialysis membrane: An
in vitro study. Artif Organs 2004;28:231-4.

45.

Jaber BL, Gonski JA, Cendoroglo M, Balakrishnan VS, Razeghi P, Diniarello
CA, et al. New polyether sulfone dialyzers attenuate passage of cytokine-inducing
substances from Pseudomonas aeruginosa contaminated dialysate. Blood
Purificat 1998;16:210-9.

46.

ANZSN. Consensus Statement for Maintenance of Chemical and Microbiological
Safety of Haemodialysis Water and Dialysate Systems. Sydney, Australia:
Australian and New Zealand Society of Nephrology, 1996.

47.

Linnenweber S, Lonnemann G. Pyrogen retention by the Asahi APS-650
polysulfone dialyzer during in vitro dialysis with whole human donor blood.
ASAIO J 2000;46:444-7.

48.

Lonnemann G, Sereni L, Lemke H-D, Tetta C. Pyrogen retention by highly
permeable synthetic membranes during in vitro dialysis. Artif Organs
2001;25:951-60.

49.

Weber V, Linsberger I, Rossmanith E, Weber C, Falkenhagen D. Pyrogen transfer
across high- and low-flux hemodialysis membranes. Artif Organs 2004;28:210-7.

50.

Roth VR, Jarvis WR. Outbreaks of infection and/or pyrogenic reactions in
dialysis patients. Semin Dialysis 2000;13:92-6.

51.

Müller-Calgan H. Der limulustest in der pharmazeutischen praxis. In: Scheer R,
ed. Der Limulustest. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1989:51.

19
CHAPTER 2
LITERATURE REVIEW
HOLLOW FIBER MEMBRANE (HFM) MATERIALS
The first membranes used in dialysis were composed of cellulose (Cuprophan)
and were manufactured in a flat-sheet design. In the 1970‟s, hollow fiber membranes
(HFMs) were first introduced offering laminar blood flow, low boundary layer resistance,
increased mass transport, and offering less-costly production (1). Cellulose was the gold
standard for several years because of ease in manufacturing and transport characteristics.
Cellulose membranes and derivatives thereof are currently being investigated for use in
dialysis and liver assist bioreactors.

Cellulose-acetate hollow fibers modified with

phospholipids have shown good permeability, low protein adsorption, and low fouling
due to the hydrophilic phospholipids sequestered on the outer surface of the HFM (2-3).
Similar membranes also showed better adhesion of hepatocytes and increased urea and
albumin synthesis compared to unmodified cellulose-acetate membranes (4).

Other

cellulose-acetate membranes modified with vitamin E did not demonstrate increased or
decreased biocompatibility as measured by standard lipid profiles, oxidized LDL levels,
or total antioxidant status, but did show potential decrease in overall middle-molecular
weight clearance long term (5).
New issues of biocompatibility and hemocompatibility have caused concerns that
membrane material properties could be the cause of leucopenia, complement activation,
cell activation, coagulation, and cytokine release (1). The introduction of synthetic
membranes formed with polyacrylonitrile (PAN) and polysulfone (PS) helped overcome

these issues.
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These membranes offered better biocompatibility and the ability to

specifically design transport characteristics based on size exclusion (6). PS and PAN are
often blended with hydrophilizing agents, such as polyvinylpyrrolidone (PVP) or methallylsufonate, to improve biocompatibility and provide the necessary porosity for
transport of solutes (6-8).
PS membranes have become increasingly popular for not only hemodialysis
applications, but for use in ultrafiltration, plasmapheresis, microfiltration, cell culture,
bioreactors, tissue engineering, and controlled drug release devices (4, 9-15). The reason
for this is based on the ability to design specific molecular weight cut-offs (MWCO)
while remaining structurally intact, biocompatible, chemically inert, and allowing
transport of gases, nutrients, and products. Constant improvement is being sought by
changing polymer blends to accentuate desired characteristics.
Among the more popular variations of PS is polyethersulfone (PES), which is
believed to be better for liquid transport based on increased polarity of PES compared to
PS (16). Chitosan and heparin added to PS membranes showed increased wettability and
decreased platelet, HSA, and fibrinogen adhesion (17). Surfactants are often added to PS
to increase hydrophilicity and decrease protein adsorption (18-20). Addition of SPAN-80
showed decreased macrovoid size and increased pervaporation (21). PES blended with
PEO increased water flux (due to decreased hydrophobicity) and decreased fouling (22).
The increased wettability of PEO-PS membranes arises from the hydrophilic PEO chain
being sequestered on the outer surfaces of the membranes during the phase inversion
process (20). Another experimental blend of PS-cellulose-acetate has been shown to
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increase water flux, surface porosity, but decrease rejection of proteins and metal ions
(23).
Still other membranes made of alumina are being investigated as a potential
alternative to other synthetic membranes (24). These membranes offer the advantage of
uniform pore size, pore distribution, higher hydraulic conductivity, and resistance to high
temperature, making these ceramic membranes a viable alternative.
It must be noted that desired surface and membrane matrix characteristics are
specific to the end use of the hollow fiber. HFMs used in HD must possess a MWCO
near 60 kD to ensure that major plasma proteins, such as albumin, are retained while
toxins, such as urea and β2-microglobulin (B2M), are removed. Also, HD membranes
must disallow adsorption of proteins, cells, and bacteria as this may compromise
ultrafiltration rates. Conversely, adsorption of cells is necessary in applications such as
cell culture, bioreactors, and tissue engineering.
CHARACTERIZATION OF HFMS
As stated, properties of HFMs must be investigated to determine their surface
physicochemistry, biocompatibility, and ability to perform the intended designed job.
Characterization techniques are as vast as the properties they investigate. Microscopic
methods investigate surface morphology and structure while filtration techniques show
the ability of a fiber to selectively remove or retain biological and chemical species.
For membranes used in ultrafiltration, microfiltration, dialysis, and perfusion,
ultrafiltration rates and sieving coefficients are vital to overall performance (25-28).
Membrane flux is often measured using the ultrafiltration coefficient (KUF) which is
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defined as the number of milliliters of fluid per hour that are transferred across a
membrane per unit pressure gradient. If the KUF is low, the permeability of water is low.
The ability of a HFM to selectively limit the transport of species of different molecular
weights is often measured using a range of dextrans. Clearance of urea and B2M, two
species of interest in hemodialysis, are also often used.
Microscopy techniques have also proven useful in analyzing pore sizes of HFMs.
Scanning electron microscopy (SEM) has been used to image both lumen surfaces and
matrix pores of HFMs. Particularly, SEM has been used to measure surface porosity and
fouling of membranes used in bioreactors (15-16, 23, 29-30). Atomic force microscopy
(AFM) is a powerful tool used to provide three-dimensional images of surfaces on the
nanoscale (25, 28, 31-33). AFM has been used to visualize membrane morphology
changes from wet to dry states (7). Also, upon phase inversion, polymeric membranes
tend to form nodules or nodule aggregates as described by Kesting (34). AFM was also
used to measure the size of these nodules as well as pore sizes (29, 32). AFM has also
been used to image cross-sections of HFMs, although such images are unclear (35).
Elemental analysis of membranes is often performed using x-ray photoelectron
spectroscopy (XPS) and nuclear magnetic resonance (NMR). These techniques are used
to deduce distribution of chemicals used in membrane fabrication. For example, XPS has
been used to determine the surface composition of PS-PVP membranes based on the
distribution of sulfur and nitrogen, components of PS and PVP, respectively (26, 36).
NMR has been used to measure bulk chemical characteristics (18).
Water contact angle measurement (CAM) is often used to learn about surface
chemistry and wettabililty of a surface (36). However the size and morphology of HFMs
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causes an inherent problem with CAM. One method used an instrument to view the
meniscus of water in a HFM (29). Another method used a form of goniometry to
measure dynamic water contact angle (29). While these methods are useful in measuring
advancing and receding contact angle, there are limitations to measuring static water
contact angle.
Biocompatibility of HFMs used in dialysis, bioreactors, and cell culture must be
addressed for each membrane type used. Often adsorption of blood proteins, platelets,
and heparin are investigated (7, 18, 37). Activation of lactate dehydrogenase can also be
used to test biocompatibility in vivo (7). Fibrinogen and HSA adsorbed to an AFM tip
has yielded data on attraction of proteins to surfaces of PS-PVP membranes (38).
Other methods used to investigate membrane fouling are confocal laser scanning
microscopy (CLSM) and time-of-flight secondary ion mass spectroscopy (30, 39-40).
While these methods can provide important data on the fouling behavior of HFMs, the
resolution of the collected images is generally low.
CLEANING OF HFMS
There exist numerous sterilization procedures used on medical and ultrafiltration
devices of which ethylene oxide, irradiation, and steam autoclaving are the most popular
(41). Also, filters used in ultrafiltration and dialysis often undergo reprocessing using
bleach, citric acid, formaldehyde, and peracetic acid.

Choice of sterilization and

reprocessing procedure can have dramatic effects on membrane physicochemistry and
biocompatibility.
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Sterilization techniques
Ethylene oxide (ETO) gas is often used as a sterilant where high temperatures
would be detrimental to the properties of the sterilized material. This small gas (MW =
44.1 g/mol), is capable of penetrating most materials, killing any organisms.

The

unstable structure of ETO allows it to react with various functional groups of proteins and
nucleic acids (42).

Because the first hollow fiber membranes were composed of

cellulose, this method of sterilization was the preferred choice. However, residual ETO
can cause adverse reactions in biological environments. In dialysis, “first-use syndrome”
was found to be caused by residual ETO in dialyzers following initial sterilization (43).
With the introduction of PS membranes, the choice of steam-sterilization became
a possibility. However, there have been conflicting reports about the biocompatibility of
steam-sterilized HFMs. In 1992, Link and Büttner suggested steam sterilization was a
better option compared to irradiation and ETO (44). Also, in 1998, steam-sterilized
dialyzers were shown to be more biocompatible than ETO sterilized membranes based on
several markers including white blood cell count and complements C3a and C5a
(anaphylatoxins) (45). However, in 2002, another study reported that steam sterilization
does not cause a decrease in cytokine release compared to ETO sterilization (46). The
debate is ongoing as to the most appropriate sterilization technique for HFMs.
Irradiation is becoming an increasingly popular method of sterilizing medical
equipment. An advantage to using irradiation is that the material may be packaged and
sealed prior to sterilization. While gamma-irradiation has been the most commonly used
method, electron beam (e-beam) sterilization is becoming increasingly popular due to
cost-efficiency and quick turnaround times (as short as 5 minute treatment) (47-48). E-
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beam systems use high energy electrons to inactivate any biological substances on a
material (48).

The energy of the electrons in the beam determines the depth of

penetration of the electrons into the material. The power of the beam determines the
absorbed dosage of radiation at a given conveyor belt speed. The radiation dosage
determines the effectiveness of microbial inactivation. The System International (SI)
dose unit is the gray (Gy), defined as 1 joule of energy deposited per kilogram of treated
material. Typical dosage used in the United States and Europe is 25 kGy (47, 49),
however, dosage is determined by the bioburden of the material being irradiated. At this
level, the probability of a viable organism existing on the material (activation coefficient)
is 10-6.
E-beam sterilization, however, can potentially cause structural changes to
polymeric materials. It has been reported that PS has a high radiation stability under dose
conditions as extreme as 104 kGy (50). Conversely, cross-linking of polymers, including
PVP, and restructuring of chemical bonds using e-beam radiation has been investigated
(51-53). While the typical irradiation dosage of 25 kGy is 1% of the dosage necessary to
reduce mechanical strength of PS by 50%, it can be suggested that physical and chemical
properties may be altered by e-beam systems (50).
While most studies on sterilization procedures focus on biocompatibility issues of
materials, changes in physicochemistry are not typically reported. It has been shown that
e-beam systems may cause some physical or chemical changes, while steam sterilization
may also alter some membrane properties if the glass-transition temperature of the
material is lower than the autoclave temperature (42). Chemical and morphological
changes to materials undergoing ETO treatment have not typically been investigated.
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Reprocessing techniques
Closely related to sterilization procedures is reprocessing techniques. While not
all HD clinics reprocess dialyzers, the practice is still in use for HD dialyzers and UF
filters. Much like sterilization processes, reprocessing procedures may cause changes in
biocompatibility and physicochemistry.
Reprocessing using bleach has been shown to cause dramatic changes in
membrane properties and overall performance. Because the reactivity of bleach is high,
exposure times need not be long (as low as 2 minutes). However, to understand the
effects of bleach, longer exposure times have been investigated, especially for HFMs
used in UF applications. Short bleach times (5 minutes) coupled with a formaldehyde
rinse showed an increase in B2M clearance (27). Longer bleach times (from 0.5 hours to
several days) showed increases in flux, increases in pore size up to 7 times, and
embrittlement as measured by fiber tensile strength, and net negative charge in PS
membranes (26, 54-56). The increased pore size could be attributed to chain scission of
PVP via radical reactions as reported (57). An advantage of using bleach is the ability of
such treatments to wash membranes of any residual plasma proteins accrued during HD
treatment (55).
Because bleaching has been shown to cause changes in membrane properties,
other means of reprocessing have been investigated. Peracetic acid and heated citric acid
are widely used because they are less destructive to membrane properties. Renalin®, a
solution composed of peracetic acid, acetic acid and hydrogen peroxide, has gained
popularity for reprocessing HD dialyzers. Peracetic acid has been shown to restore
clearances of urea and vitamin B12 (58). However, peracetic acid has been shown to not
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fully wash membranes of accumulated plasma proteins, resulting in decreased clearance
of B2M and larger molecular weight dextrans (27, 55, 58). Heated citric acid increased
clearances of B2M and fully restored urea clearances in PS membranes.
Much like the choice of sterilization technique, reprocessing of hollow fibers
remains a topic of debate. Choosing a reprocessing technique greatly depends on the
membrane being used and the desired properties to be attained.
REMOVAL OF LPS FROM SOLUTIONS
Removal of LPS from dialysate and water solutions
Because of the possibility of bacterial and LPS contamination in water and
dialysate, these solutions must be sterilized prior to use. LPS molecules exhibit high heat
stability, requiring temperatures above 180oC to inactivate (59). Therefore other means
of eliminating LPS from solutions have been sought. Removal of LPS from solution is
generally achieved using affinity sorbents and filtration. Plasma exchange, charcoal
hemoperfusion, and immobilization to polymyxin B (PMB), ceramic membranes, and
functionalized nanoparticles have been investigated with varying degrees of success (6064). Other chemistries exhibiting a high affinity for LPS include poly-L-lysine (PLL),
diethylaminoethane, histamine, and histidine (65). Cationic polyelectrolytes presumably
bind to the negatively charged phosphate groups on LPS. Ultrafiltration of water prior to
dialysate preparation has been shown to be effective in eliminating most LPS and
bacteria from solution (66-68).
Because the dialysis membrane represents the final barrier in preventing backfiltration of LPS to the blood side of the membrane, several studies have focused on
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bacterial retention properties of HFMs. The means of prevention has been ascribed
primarily to adsorption, with filtration also playing a vital role (69-70). Certain PS,
polyamide and cellulose membranes have been shown to stop back-filtration (69, 71-72).
However, it has also been shown that other PS and PES membranes of similar
characteristics prevent back-filtration of LPS to different degrees, indicating that specific
membrane characteristics contribute to the overall performance of inhibiting transmembrane LPS flux (69, 73-74). LPS transfer was shown to occur as quickly as 10
minutes (74). Also, increased LPS loads in the dialysate compartment led to increased
back-filtration (75-76).
One study showed that LPS readily bound to hydrophobic domains on polyether
polymer alloy (PEPA) and polymethyl-methacrylate (PMMA) membranes, but not to
hydrophobic domains (77).

Similarly, another study showed that preventing back-

filtration of LPS increased when a hydrophobic outer layer existed on the HFM and that
the presence of PVP increased chances of LPS leaking into the blood compartment (70).
The presence of an outer hydrophobic skin to bind LPS could prove valuable because it
has been shown that LPS does not have to be in direct contact with blood to elicit a
pyrogenic response (78).
Other researchers have focused on reducing serum levels of LPS due to either
LPS back-diffusion or infections. Sevelamer hydrochloride (commonly known under the
trade name Renagel®) has been shown to bind free LPS in solution and that free
phosphate in solution causes positive cooperative binding of LPS (79). Also, a system
using immobilized albumin has been shown to remove LPS in hemoperfusion tests (80).
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Removal of LPS from biological solutions
During protein purification of solutions prepared using gram-negative bacteria, it
is necessary to remove LPS during a purification step. While extraction of intracellular
proteins from whole yeast cells has been reported, destruction of bacterial cells via some
external process is usually necessary to remove unsecreted proteins (81).

Often

disruption of cells is performed by high-pressure homogenization, after which filtration,
two-phase extraction, and/or an adsorption process removes LPS (82). Because LPS may
interact with proteins in solution, LPS can often be “hidden” from removal processes
(83). Also, removal processes largely depend on the properties of the protein of interest
as the protein may degrade under extreme pH, temperature, or ionic strength. Current
methods of removing LPS using each of these techniques will be briefly discussed.
Because LPS usually exists in micelles, separation from small proteins via
ultrafiltration is commonly used. One study showed that adding Ca2+ and LPS monomers
to a solution caused large aggregates of LPS (as in Fig. 1.4) for easier removal with
filtration (84). However, some proteins interact with high concentrations of Ca2+, and
therefore, this method is limited in its use. Also, because many proteins are larger,
ultrafiltration is not a viable option. Therefore, other methods are more commonly used.
Above a critical micelle concentration, detergent combines with lipid A of LPS
forming micelles which separate from solution.

A number of detergents are being

investigated including those of the Triton X series. Triton X-114 detergents have been
shown to be effective at removing LPS from solution (85-87). Above a “cloud point”
temperature, micelles separate to the bottom of a solution into a micelle-rich phase, while
the upper portion of the lipid contains a micelle-poor phase. Centrifugation is commonly
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used to facilitate further separation. Subsequent additions of detergent and centrifugation
steps can eliminate LPS further.
Perhaps the most common methods of removing LPS from solutions involve the
use of an adsorbent (polycationic, immunoaffinity) either in conjunction with filtration or
through chromatography. Numerous studies have explored the use of each of these
techniques. However, it must be noted that preferred methods are usually dependent on
the properties of the proteins in solution.
Linking an adsorbent to a chromatographic membrane has been shown to be
effective at selectively removing LPS from a solution (65, 88). Anspach and Hilbeck
(65) coated sepharose beads with PLL, PMB, histidine, histamine, and DEAE. They
showed excellent removal of LPS from solution at low and neutral pH, but weak
adsorption at a pH of 8.5, possibly due to the some deprotonation of the adsorbents (only
histidine and histamine have pKa lower than 8.5). Also, all showed good recovery (>
90%) of lysozyme at low and neutral pH, but less (< 90%) recovery at pH 8.5. PLL
showed the best recovery of BSA at low and neutral pH, while DEAE performed worst.
Another group bound Iron(III) to a chromatographic matrix for LPS removal (89).
While chromatographic methods are often used, it has been shown that under
certain conditions, use of an adsorbent-linked filter was more effective at removing LPS
from solution (90).

It was shown that PEI and PLL removed more LPS, while

maintaining over 90% BSA recovery.

However, as with similar chromatographic

methods, removal of LPS and recovery of protein was highly pH dependent. Similarly,
another study showed over 99% removal of LPS from a solution containing BSA using a
nylon membrane containing several adsorbents including PLL, PMB, PEI, and DEAE
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(91). Addition of a chelating agent increased LPS adsorption slightly in all cases except
DEAE. Others have used polycationic adsorbents attached to cellulosic membranes to
remove over 90% of LPS while allowing over 90% recovery of BSA (92).
While most methods of binding an adsorbent to a filter membrane often use crosslinking agents, one group has explored the idea of including a charged monomer during
the formation of a membrane to provide a charged surface for binding LPS (93). This
method could prove valuable as filtration characteristics of the membrane can be custom
tailored.

Adsorbent-based filtration membranes modified through cross-linking may

experience clogging of pores, thus lowering effective pore size.
Others have explored adding adsorbents directly to solutions to first bind LPS in
solution, then using filters to remove large aggregates. Cross-linked granular chitosan
and water insoluble poly-ε-lysine have both been used for this purpose (94-95). The
poly-ε-lysine also allowed excellent recovery of a diverse array of proteins (including
BSA, insulin, myoglobin, gamma-globulin, and cytochrome c) after filtration through
cellulose acetate membranes.

Submicron-sized polystyrene-coglycidyl-methacrylate

beads modified with several chemistries were explored for LPS-binding capabilities (64).
Cross-linked lysine monomers were shown to be very effective, whereas PEI and PMB
were less effective.
As shown, lysine represents an effective adsorbent for LPS. Modifications, using
this polyelectrolyte, to hollow fiber membranes used in filtration will be explored in
Chapter 5.
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CHAPTER 3
EFFECT OF STERILIZATION TECHNIQUES ON PHYSICOCHEMICAL
PROPERTIES OF POLYSULFONE HOLLOW FIBERS 1
ABSTRACT:

Sterilized hollow fiber membranes are used in hemodialysis,

ultrafiltration, bioprocessing, and tissue engineering applications that require a stable and
biocompatible surface.

Here

we

demonstrate significant

changes

physicochemical properties depending on method of sterilization.

in

fiber

Commercial

polysulfone hollow fibers containing poly(vinylpyrrolidone) were subjected to ethylene
oxide (ETO), sodium hypochlorite (bleach), and electron-beam (e-beam) sterilization
techniques followed by analysis of surface hydrophilicity, morphology, and water
retention ability. E-beam sterilized fibers had contact angles near 48° compared to the
ETO and bleach treated fibers, which were each near 56°. Atomic force microscopy
revealed lumen RMS roughness values near 19 nm for all three sterilization methods;
however, e-beam sterilized and bleach treated fibers had significantly higher (~106 nm)
RMS values for the outer wall as compared to the ETO sterilized fibers (~39 nm). The
increased hydrophilicity and surface area of the e-beam sterilized fiber was reflected by a
greater water evaporation rate than the ETO treated fiber. These results demonstrate
common

sterilization

methods

may

significantly

alter

polymer

membrane

physicochemical properties, which may in turn impact surface fouling. For tissue
engineering and bioprocessing applications, these changes may be leveraged to promote
cell adhesion and spreading.

1
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INTRODUCTION
The surface physicochemical properties of hollow fiber membranes (HFMs) are
of significant importance as they influence ultrafiltration rates, as well as dictate whether
biological components (proteins, cells, bacteria) adsorb to the membrane, which may be
favorable in cell culture, bioreactor, and tissue engineering applications (1-3), but less
desirable in ultrafiltration applications where biofouling diminishes filtration efficiency
(4-7). HFM fabrication procedures, including polymer/copolymer and solvent selection,
as well as post-fabrication processing and sterilization methods, influence HFM surface
chemical and physical properties, impacting overall performance of the membrane.
Polysulfone (PS) and cellulose acetate are the most common materials used in
HFM production, chosen based on their structural integrity, ease in manufacture, and
biocompatibility. Common copolymer additives include poly(vinylpyrrolidone) (PVP),
polyvinylidene fluoride, polyetherimide, poly(ethylene oxide), and phosphorylcholine
polymer (1, 8-12). These copolymers are necessary to form the pore structure in the
membrane through phase inversion.

Because PS membranes are used in many

applications, particular interest has been given to analyzing and altering membranes
containing this polymer and the commonly-used hydrophilic additive, PVP. Here we
characterize the physicochemical properties of pure PS and PS-PVP membranes
following several common sterilization methods.
The influence of sterilization on HFM properties and performance is of significant
importance, especially for multi-use devices subjected to repeated sterilization cycles. As
this is the last step before application (or re-use), its influence is often overlooked.
Common biomedical material sterilization methods include steam autoclaving, ETO gas,
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irradiation, or exposure to several chemical sanitizers such as sodium hypochlorite,
hydrogen peroxide, sodium hydroxide, or ethanol. Here we focus on ETO, e-beam, and
bleach treatments to compare common gas, irradiation, and chemical sterilization
methods.
Several methods have been used to study the properties of HFMs including
scanning electron microscopy (SEM), atomic force microscopy (AFM), contact angle
measurement (CAM), X-ray photoelectron spectrometry (XPS), ultrafiltration rate,
protein adsorption, and tensile strength (4, 8, 10-18). We present a method for sectioning
hollow fibers to expose the lumen as a flat surface for CAM and AFM analysis.
Additionally, water evaporation rate from the membrane is presented as a sensitive
method to characterize membrane hydrophilicity and sorption properties.
Applying AFM, CAM, and water evaporation techniques we demonstrate
dramatic changes in HFM surface roughness and hydrophilicity as a function of initial
chemistry and sterilization technique. The results demonstrate how common sterilization
methods may inadvertently change membrane properties, as well as provide simple postfabrication methods to tune properties toward specific applications.
MATERIALS AND METHODS
Membrane preparation
All hollow fiber membranes used in this study were prepared by Fresenius
Medical Care North America. ETO and e-beam sterilized fibers were obtained from the
commercial dialysis cassettes Fresenius Optiflux® F200NR and F200NRe, respectively,
with each having an aqueous KUF of 200 mL/h·mm Hg and an albumin sieving
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coefficient of 0.45%. These membranes are manufactured using a polymer blend of PS
and PVP; their respective structures are shown below:

CH3
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O

C

O

O

CH3

H2C

S
n

CH
N

n

O
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PS hollow fiber membranes were fabricated on a pilot line using polysulfone
without any other polymer additives.

This fiber group was not subjected to any

sterilization technique, serving only as a control to compare with PS-PVP membranes.
Bleach treated F200NR fibers were subjected to 0.57% effective sodium hypochlorite
content from the dialysate side at 70oC for 2 minutes. All hollow fiber membranes were
prepared with the same spinning parameters (spinneret size, air gap, bore fluid, rinsing
time), producing asymmetric membranes similar to that shown in Fig. 3.1, with a
compact filtering layer at the inner surface and a porous matrix structure through the
remainder of the fiber cross section.
Hollow fibers were sectioned to access the lumen for both AFM and CAM with
the aid of a stereo microscope (SMZ645, Nikon Corp.). Fibers were fixed on doublesided tape, cut longitudinally with a razor blade, spread open, and rolled flat using a clean
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FIG. 3.1. SEM of PS-PVP asymmetric dialysis hollow fiber [19].
glass test tube. Intact fibers were also rolled flat on double-sided tape to present the
outside of the fiber as a flat surface.

Water contact angle measurement
Water contact angles of fibers were obtained using a VCA Optima (AST
Products, Inc.). Measurements (n = 8) were made on both the lumen and outside of
hollow fibers with 0.25 μl droplets of double distilled water (MP-3A, Barnstead Intl.) at
25oC. Statistical analysis was performed on WCA measurements and all subsequent data
sets using two-population t-tests in Origin® software (v6.1052, OriginLab Corporation).

AFM morphology
Sample surface morphology and roughness were observed using a Bioscope AFM
(Nanoscope IIIa, Digital Instruments, Inc.) in tapping mode using a silicon nitride
cantilever (40 N/m, Tap300, Budget Sensors). A scan size of 2 x 2 μm2 for the lumen of
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the fibers was chosen to show the nanostructure of the membranes. A scan size of 10 x
10 μm2 for the outside of the fibers was chosen to show macrostructures of the porous
membranes.

The root mean square (RMS) roughness was measured (n = 5) using

Nanoscope III imaging software (version 5.30r3, Digital Instruments, Inc.).

Lumen

particle sizes were calculated using a previously described method (n ≥ 30) (14).

Water evaporation rate
Water evaporation rates for hollow fibers were obtained using a tensiometer,
μtrough S (Kibron, Inc.).

One-inch lengths of hollow fibers were affixed to the

tensiometer wire probe using a small piece of double-sided tape, brought into contact
with water in a reservoir, and allowed to equilibrate for at least two minutes to reach
maximum absorption capacity (25oC, 24% relative humidity). Upon removal from the
water reservoir, the evaporation induced and change in mass was recorded over time.
Water evaporation rates for the fibers were calculated from the change in mass over 2
minute time periods. This method offers distinct advantages over using a standard
analytical balance in terms of sensitivity of the instrument (< 0.1 μg), instrument
equilibration time, and reduced variability due to sample transfer and user error.
RESULTS
Surface hydrophilicity by CAM
Contact angle measurements were performed on the lumen and outside of PS and
PS-PVP fibers to compare wettability of each surface. Results for the contact angle
measurements are presented in Fig. 3.2. Statistical analysis was conducted to show
significant difference between outer and lumen contact angles and among the different
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FIG. 3.2. CAM of hollow fibers, both lumen (dark) and outside (light). Mean ± s.d., n =
8. PS and e-beam sterilized fibers show higher and lower contact angles, respectively,
than the ETO sterilized and bleach treated fibers (p < 0.05). The 2-minute bleach treated
fiber had identical contact angle to the ETO fiber. Fibers bleached for 1 hour showed
contact angles approaching those of PS fibers (data not shown).
membrane types. The ETO sterilized and 2-minute bleach treated membranes had nearly
identical contact angles (~56o), suggesting similar fiber surface properties. Longer (1
hour) bleaching times significantly increased the contact angle to 73o (data not shown)
suggesting loss of hydrophilic PVP with time. Contact angles for bleached flat-sheet
membranes formed using the same polymer chemistry are shown in Fig. A.1 (Appendix
A). In contrast, e-beam sterilization led to a significant lowering of water contact angle
(~470) as compared to the ETO sterilized and bleach treated membranes (p < 0.05). As
expected, the pure PS fiber had significantly higher water contact angle (> 80o) than any
other membrane due to lack of PVP. There was no significant difference between inner
skin and outer membrane for each fiber type.
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FIG. 3.3. AFM images of the ETO sterilized hollow fiber, lumen (A) and outside (B).
The asymmetrical membrane shows nodule aggregates on lumen and porous structure on
outside.

FIG. 3.4. AFM images of e-beam sterilized hollow fiber, lumen (A) and outside (B).
Nodule aggregates for this membrane are significantly smaller than those on the ETO
sterilized membrane. Pores on the outside are also larger than those on the ETO
sterilized membrane.
AFM morphology
AFM images of the lumen and outside of each membrane type are shown in Figs.
3.3-3.6.

Images presented here were representative of all images taken for each

membrane type (n = 5). The bead-like structures seen in the lumen images of each
membrane type can be classified as nodule aggregates based on the four superimposed
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FIG. 3.5. AFM images of bleach treated hollow fiber, lumen (A) and outside (B). The
membrane is structurally very similar to e-beam sterilized hollow fibers on both lumen
and outside.

FIG. 3.6. AFM images of PS hollow fiber, lumen (A) and outside (B). Membrane is
structurally different, especially on the outside, than other fibers due to chemical
differences of PS polymer versus PS-PVP polymer blend.
tiers of structure in integrally skinned phase inversion membranes described by Kesting
[20]. Nodule aggregates are described as spherical clumps of coalesced macromolecule
groups, between which are pores responsible for membrane ultrafiltration characteristics.
Nodule aggregate sizes for the lumens of the membranes were as follows (n ≥ 30): ETO,
153 ± 49 nm; e-beam, 97 ± 32 nm; bleach, 104 ± 36 nm; PS, 130 ± 53 nm. Nodule
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FIG. 3.7. RMS roughness of hollow fibers, both lumen (dark) and outside (light). Mean
± s.d., n = 5. No significant difference among lumen RMS values is reported (p < 0.05).
Bleach treated and e-beam sterilized fibers show significantly higher RMS values than
ETO sterilized and PS fibers.
aggregate sizes for the ETO and PS membranes were similar, whereas the nodule
aggregates for bleach treated and e-beam sterilized fibers were significantly smaller (p <
0.05).
AFM images reported here show varying size and structure of the porous
membranes depending on sterilization method. Similar to the trends seen for the lumens,
the outsides of the bleach treated and e-beam sterilized fibers were significantly different
than the ETO sterilized fiber; pore sizes for these membranes were much larger. Also,
the outside of the PS membrane exhibited ill-defined pores and a skin-like structure, due
to lack of PVP during the phase inversion process.

50
1.4

Bleach
ETO
Ebeam
PS

Water Mass (mg)

1.2
1.0
0.8
0.6
0.4
0.2
0.0
0

20

40

60

80

100

120

140

Time (sec)

FIG. 3.8. Averaged evaporation profiles of hollow fibers measured by tensiometer, with
mass of absorbed water in the hollow fiber versus time (n = 9). Sensitivity of the
tensiometer probe allows for highly accurate measurements (< 0.1 μg). Error bars have
been removed for clarity.

Table 3.1. Experimental results for water evaporation rate
and water absorption of hollow fibers (n = 9).

Hollow fiber

Absorbed
Water (mg)

Water Evaporation
Rate (μg/s)

ETO
E-beam
Bleach
PS

1.13 ± 0.02
1.10 ± 0.04
1.21 ± 0.02
–

7.17 ± 0.56
7.88 ± 0.46
7.64 ± 0.40
–

RMS roughness of the lumen and outside of each fiber is reported in Fig. 3.7. No
significant difference was found among any membranes on the lumen side. However,
both bleach treated and e-beam sterilized fibers had significantly higher roughness on the
outside surfaces compared to the ETO sterilized and PS fibers. This large increase in
surface roughness arises from increased pore size as seen in the AFM images. The large
particles seen on the lumen images of both the e-beam sterilized and bleach treated
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membranes were observed on all PS-PVP membranes and were included in the
calculation of surface roughness.

Water evaporation rate
Averaged evaporation profiles for the sterilized fibers are shown in Fig. 3.8.
Calculated evaporation rates of water for hollow fibers as well as the mass of water
absorbed by the fibers are shown in Table 3.1. Due to the hydrophobic nature of the PS
polymer, no water was absorbed in the PS membranes, whereas fibers containing PVP
exhibited different degrees of water absorption. The e-beam sterilized fiber exhibited a
faster evaporation rate than the ETO sterilized fiber, while the bleach treated fiber was
not significantly different from either the ETO or e-beam sterilized fiber. All membranes
were statistically significant from all others in the amount of water absorbed.

An

increase in absorbed water could indicate a larger porosity while a faster evaporation rate
likely reflects increased porosity and hydrophilicity.
DISCUSSION
Differential effects of e-beam and ETO sterilization, and bleach treatment on PSPVP membranes are observed. In particular, e-beam and 2-minute bleach treatments
significantly increased the porosity (roughness) of the outer surfaces and decreased the
nodule size on the lumens as compared to ETO sterilization. Contact angles, however,
did not differ drastically for these three sterilization methods, although e-beam treated
fibers were slightly more hydrophilic (47-48o) compared to both ETO and bleached fibers
(55-57o).

Extended bleach sanitation time beyond two minutes increased fiber

hydrophobicity, with 1-2 hour bleach treatments yielding surface hydrophobicities
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approaching that of pure PS (81-86 ) , which are similar to previously reported values (9,
o

21). Thus fiber hydrophobicity may be selectively increased or decreased through postfabrication bleach treatment or e-beam exposure, respectively.
Sterilization methods have the potential to cause slight to major transformations
in membrane chemistry and overall performance of polymeric HFMs including
membrane shrinkage, changes in permeability, increases in pore size, and changes in
surface chemistry and charge (22-24). In addition to potentially altering membrane pore
size and ultrafiltration rate, sterilization may also compromise biocompatibility due to
changes in physicochemical properties or retention of toxic residuals, such as the case for
ETO (25-26).

Alternatively, modified surface properties may potentially favor cell

spreading and proliferation, as desired in tissue culture applications (4).

Surface

roughness and energy are key parameters determining cell-surface interactions.

As

compared to gas sterilization with ETO, e-beam and bleach treatments increased outside
surface RMS, decrease lumen nodule size, and can be used to tune the hydrophobicity in
PS-PVP membranes. Similar surface features have been observed previously using SEM
and AFM (8-9, 13-14, 27).
It has been reported that PS has a high radiation stability under dose conditions as
extreme as 104 kG (28). Conversely, cross-linking of polymers, including PVP, and
restructuring of chemical bonds at lower dosages (10-100 kG) using electron beam
radiation has been investigated (29-31). The radiation dosage used in this study (25 kG)
is similar to that used in current sterilizing medical equipment (32-33). While this dosage
is approximately 1% of the dosage necessary to reduce mechanical strength of PS by 50%
(28), it can be suggested that physical and chemical properties of membranes are indeed
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altered here. E-beam sterilization in this study lowered contact angle for the lumen and
outside surfaces by approximately 8o (compared to the ETO sterilized and bleach treated
membranes), and increased surface roughness on the outside of the membrane by 2.7
times relative to the ETO sterilized membrane. Also, decreased nodule aggregate size
compared to the ETO sterilized membrane may indicate changes in polymer interactions.
While the e-beam radiation dosage used in this study was small, it was sufficient to cause
slight, but significant, chemical changes throughout the fiber matrix and physical
restructuring on the outside and lumen of the membrane.
Bleaching of HFMs as a sterilization or reprocessing technique has been shown to
affect many membrane characteristics including surface chemistry, membrane
permeability, pore size, and polymer chain molecular weight (18, 22, 34-36). While
reprocessing times often differ based on technique, bleaching times of 2 minutes used in
this study are within the time frames tested previously (35, 37-38). It has been shown
that PVP is washed from membranes treated with bleach for long periods of time (48
hours) due to chain scission via radical reactions (39), and that luminal and outer surface
nitrogen content (due solely to PVP) decreased significantly with bleach times from 1
hour (22). We found one hour of bleach treatment led to contact angles of 73.3o for the
outside of fibers, approaching that of PS membranes. Due to some PVP being washed
out of the bleach treated membranes, a larger percentage of the membrane surface would
consist of the more hydrophobic PS. Results presented here for fibers bleached for 2
minutes show no significant change in contact angle of hollow fiber membranes
compared to the ETO fibers, implying little change in surface chemistry due to PVP
removal from the polymer matrix. Thus, the increased roughness and porosity in the
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outer membrane and decreased nodule size in the lumen following bleaching is unlikely
the result of PVP removal.
HFMs treated with solutions containing bleach for 2 minutes have been shown to
increase clearances of β2-microglobulin, suggesting increased pore sizes and/or decreased
nodule aggregate sizes on the lumen surface of the membrane (35). Rearrangement of
polymer molecules upon bleach treatment may have caused a decrease in polymer
aggregate size as seen here and in previous reports, but left the overall chemistry of the
polymer membrane unaffected, yielding a membrane of equal surface hydrophilicity to
the ETO sterilized membrane (9, 18).
That the bleach treated and e-beam sterilized fibers were much different than the
ETO sterilized fiber could be explained by the methods of polymer restructuring
discussed above for these sterilization techniques. Larger pore sizes for the outside of
these membranes could cause an increase in solute transfer and weakening of the fiber
structure (18, 22, 35). Increased solute transport could be of importance in both filtration
and cell culture applications, while weakening of fiber structure is of concern in
applications where high trans-membrane pressures are used.
Water evaporation rates of hollow fibers can give an indication of surface and
bulk properties, such as porosity and wettability. In cases such as vapor permeation, the
ability of a membrane to retain certain liquids, including water, can be very useful (4041). Results shown in Fig. 3.8 and Table 3.1 indicate different evaporation profiles for
ETO and e-beam sterilized fibers. Restructuring of fiber morphology, as previously
discussed, could indicate an increase in surface area of the e-beam sterilized fiber
compared to the ETO sterilized fiber. E-beam induced chemical changes as inferred by

decreased water contact angle likely enhance wicking or spreading of water.
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The

increased surface area and hydrophilicity thus facilitate water evaporation from the ebeam sterilized fiber. Based on the data, it can be noted that water retention abilities
(water evaporation rates) can be altered based on sterilization technique.
The mass of water absorbed by each fiber type was significantly different in each
case. As noted in Table 3.1, the bleach treated fibers absorbed the largest quantity of
water. The breakdown of the matrix of hollow fibers in contact with hypochlorite
solutions as seen in SEM micrographs has been reported (34). Although the exposure
time of hypochlorite tested in that study was significantly longer than the exposure time
here, it can be assumed that a similar, yet less intense, breakdown would occur. Because
of this increase in membrane porosity, more water would be absorbed. Conversely,
despite having a surface morphology similar to that of the bleach treated fiber, the ebeam sterilized membrane absorbed less water than the ETO sterilized and bleach treated
membranes. Fiber matrix properties not observed in the AFM images may have been
slightly changed upon e-beam treatment, allowing less water to be absorbed.
The changes described here for sterilized PS-PVP HFMs have specific application
to their fields of use. HFMs used in ultrafiltration, especially hemodialysis, must exhibit
specific physicochemical characteristics including pore size, surface wettability, and
biocompatibility. The fibers investigated showed hydrophilic surfaces with porous inner
membranes similar to those used in clinical application. Because PS-PVP membranes
have become an interesting surface for cell culture, bioreactors, and tissue engineering
due to the ability of the polymer to be formed into specific geometries (i.e. for cell
encapsulation), it is necessary to consider physicochemical changes in these membranes
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post-sterilization. PS-PVP membrane biocompatibility has been attributed to a “cushion
effect”, where an increase in regularity of polymer structures in wet conditions led to
decreased platelet and fibrinogen adhesion (8, 9).

The largest increase in platelet

adhesion was achieved by more hydrophobic surfaces that had a smaller concentration of
PVP at the surface of the membrane. However, it has also been shown that islet cells
better adhere to PS and PS-PVP films than to more hydrophobic polystyrene, indicating
surface wettability is just one factor affecting cell adhesion to a surface (4).
CONCLUSION
The present study focused on characterizing and comparing physicochemical
properties of hollow fiber membranes subjected to several sterilization procedures using
contact angle measurement, atomic force microscopy, and water evaporation rate. The ebeam sterilized fiber exhibited a modest decrease in water contact angle compared to
both ETO sterilized and bleach treated membranes and a higher water evaporation rate
than that of the ETO sterilized membrane. Also, the e-beam sterilized and bleach treated
membranes both had larger outside surface RMS values and smaller lumen nodule
aggregate sizes compared to the ETO sterilized membrane. These findings indicate
significant changes in both physical and chemical properties of the membrane surface and
possible changes to the porous matrix for different sterilization techniques. This has
significant implications regarding selection of sterilization methods given the diverse
range of hollow fiber applications, including ultrafiltration, cell culture, and tissue
engineering.

While detrimental effects to membranes such as altered mechanical

properties, surface fouling ability, and ultrafiltration must be considered, sterilization-
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induced changes to surface characteristics also provide a facile means to altering
membrane surface roughness and energy, which may be leveraged to promote cell
adhesion and spreading for tissue engineering and bioprocessing applications.
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CHAPTER 4
HEMODIALYSIS MEMBRANE SURFACE CHEMISTRY AS A BARRIER TO
ENDOTOXIN TRANSFER1

ABSTRACT:

The transfer of bacterial endotoxin (lipopolysaccharide, LPS) from

contaminated dialysate solution to a patient‟s blood during hemodialysis is a serious
complication triggering fever and possible systemic shock. This study investigated LPS
transfer across native and modified Fresenius Optiflux® F200NRe polysulfone (PS)
fibers. Modifications included: bleach-treated, high-PVP, low-PVP, and a copolymer
mixture of PS-PEG. Fibers were exposed to 400 EU/ml of LPS from two bacterial
sources under conditions modeling a clinical situation (2 hrs countercurrent flow, with
saline substituted for blood). Kinetic turbidimetric limulus amoebocyte lysate (LAL)
assay of the saline was performed to assess LPS transfer across the membranes. Water
contact angle analysis and SEM were performed to correlate LPS transfer to material
properties.

LPS labeled with AlexaFluor 594 was used for fluorescence studies.

Fluorescence images were taken of 10μm sections to observe LPS distribution. LPS
adsorbed predominantly near the lumen of all membranes except the copolymer
membrane, where LPS localized on the outer wall. LPS was not detected (<0.1 EU/ml)
in the blood side of the Optiflux fibers, but was detected in all other samples (>0.1
EU/ml). High-PVP fibers allowed the greatest transfer of LPS to the blood side while
adsorbing very little LPS. Low-PVP fibers promoted adsorption of LPS with very little

1
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transfer to the blood side. Results indicate surface chemistry can be tuned during fiber
production to control LPS adsorption and distribution across hollow fibers.
INTRODUCTION
Recent attention in the dialysis community has focused on back-filtration of
bacterial endotoxin from contaminated dialysate (1-3).

The trend toward high-flux

dialyzers, because of their ability to remove large percentages of middle molecular
weight toxins such as β2-microglobulin (MW 11 kDa), has increased the concern of
possible bacterial contamination in dialysate (4-5).

Bicarbonate dialysate, an ideal

environment for bacterial growth, is usually used in conjunction with high-flux
membranes due to its biocompatibility (6).
Bacterial endotoxin (lipopolysaccharide, LPS) is a surface-recognition constituent
of gram-negative bacterial membranes consisting of 3 main parts: an outer-membraneintegrated lipid (lipid A), a core oligosaccharide, and a long heteropolysaccharide chain
(O-antigen) (7).

The O-antigen varies among different bacterial strains and is the

recognition site for blood-borne antibodies. The lipid A portion is generally conserved
among bacterial types and is responsible for causing pyrogenic reactions. LPS is an
amphiphilic molecule that has been shown to preferentially adsorb to hydrophobic
surfaces (3). Endotoxin size varies from monomers of 10 kDa, to micelles of 1000 kDa
or larger (7-9).
Bacterial contamination in dialysate fluids and clinical water sources has been
documented (10-13). A diverse community of culturable bacteria has been found in
dialysate fluids, of which Pseudomonas is most common (14-17).

Robust, sessile
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bacterial communities, called biofilms, may present a persistent source of contamination
in dialysate water production lines because they are difficult to detect and remove (1113). Several studies on water and dialysate quality in clinics in the U.S. and Europe have
shown that as many as 20% of the samples tested were above the limit of the
recommended standards (4, 16, 18). While small quantities of contamination may not
always elicit a pyrogenic response, continued exposure to contaminated dialysate is of
great concern because a typical patient on hemodialysis therapy will be exposed to
18,000-30,000 liters of water annually (17, 19). Reported pyrogenic reactions up to 0.7
per 1000 treatments have been reported, due mainly to pre-treatment issues with dialysis
water (6, 17, 20).
Removal of LPS from solution is generally achieved using affinity sorbents and
filtration. Plasma exchange and charcoal hemoperfusion, as well as immobilization to
polymyxin B, ceramic membranes, and functionalized nanoparticles, have been
investigated with varying degrees of success (4-5, 9, 21-22).

Other chemistries

exhibiting a high affinity for LPS include poly-L-lysine, diethylaminoethane, histamine,
and histidine (23). Cationic polyelectrolytes presumably bind to the negatively charged
phosphate groups on LPS.
The physicochemical properties of dialysis membranes are also explored to
prevent back-filtration of LPS to the blood side of the membrane.

The dialyzer

represents the final barrier in preventing back-filtration of cytokine-inducing substances,
such as LPS. Studies have shown that membranes of polysulfone (PS), polyamide, and
cellulosic tri-acetate were effective at stopping back-filtration (1, 10, 24-26). The means
of prevention has been ascribed primarily to adsorption, with filtration also playing a
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significant role (1-2). However, it has also been shown that membranes of similar
characteristics prevent back-filtration of LPS to different degrees, indicating that specific
membrane characteristics contribute to the overall performance of inhibiting transmembrane LPS flux (1, 3, 19).
The present study focuses on the mechanism by which several membranes of
different chemical properties remove LPS, utilizing endotoxin from cultured sources and
fluorescently-labeled conjugates. The membranes were challenged using both convective
and diffusive experimental setups, as previously described (1). We present here how
polyvinylpyrrolidone (PVP) content can be altered to encourage LPS adsorption and limit
back-filtration. Furthermore we show how fiber sterilization via bleaching, as well as the
addition of polyethyleneglycol (PEG) to polysulfone (PS) membranes, affects LPS
adsorbing capabilities of dialysis membranes.
MATERIALS AND METHODS
Membranes
All experimental fibers were produced using the phase-inversion solution
precipitation method (27) with the same spinning parameters (spinneret size, air gap, bore
fluid, rinsing time). Fresenius Optiflux® F200NRe membranes (Fresenius Medical Care
North America), PS-PVP membranes sterilized via electron-beam irradiation, were used
as the control against which experimental fiber membranes produced on a pilot line
(FMCNA, Ogden, UT) were compared. Three experimental fibers were produced using
PS as the base polymer with PVP as an additive or PEG as copolymer: High-PVP, LowPVP, and PEG-Copolymer. “High” and “low” PVP content is with respect to that in the
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commercial Optiflux membranes (28). Bleach-treated Optiflux fibers were prepared
through exposure to 0.57% effective sodium hypochlorite content from the dialysate side
at 70oC for 2 minutes. Short bleach times were used similar to previous studies in order
to limit possible membrane damage (29-30). Seiving coefficients for the different fibers
used in this study are shown in Fig. C.1. (Appendix C).

Dialysate with bacterial culture filtrates
The contaminated dialysate challenge solution was prepared by inoculating two
solutions of Trypticase soy broth (TSB) media with Stenotrophomonas maltophilia
ATCC 13637 and Pseudomonas aeruginosa ATCC 27853, respectively. Following 48
hours of incubation, cultures were ultrasonicated (2 minutes at room temperature) and
successively filtered using decreasing pore size, with a resulting final filtration at 0.45
μm. The large pore size used here maximized LPS fraction with no noticeable activity
aberrations during the testing period. The remaining bacterial culture filtrates were then
combined, rendering a challenge solution with LPS from both organisms. From this
concentrated stock, bicarbonate dialysate was spiked to obtain LPS concentrations
between 200-500 EU/ml in the dialysate. Challenge dialysate was kept at 4oC until used.

In vitro dialysis circuit
A model of in vitro dialysis previously described was modified for this study (Fig.
4.1) (19). Standard-sized dialysis cassettes were used for the in vitro studies (n = 3).
Pumps connected to the blood compartment (BC) and dialysate compartment (DC) were
first calibrated using sterile saline. Standard dialysis tubing sets (Medisystems) were
sterilized and assembled prior to running the dialysis simulation, according to the
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experimental setup in Fig. 4.1. Both the BC and DC were then rinsed with pyrogen-free
saline for 15 minutes, to remove any residual endotoxins. Following the saline rinse, the
simulation commenced by closing the BC circuit (closed loop) and introducing the
dialysate challenge solution to the DC circuit (420 ± 24 EU/ml). The flow through the
BC circuit was held constant at 200 ml/min, using a reservoir of approximately 140 ml,
while flow through the DC circuit was 500 ml/min. After 60 minutes, the BC return line
was placed in the dialysate challenge reservoir and the inlet blocked, forming a
convective circuit as shown in Fig. 4.1. The flow from the BC was lowered to 37 ml/min
and the simulation was run for an additional 60 minutes, followed by a saline rinse.

FIG. 4.1. Experimental dialysis simulation setups for the LPS challenge tests. The
diffusive setup is first run for 60 minutes, after which the system is changed to the
convective setup and run for an additional 60 minutes.
Samples of 10 ml were collected from both the BC and DC following the priming
saline rinse, and at time 0, 7, 15, 60, 67, 75, and 120 min during the LPS challenges. LPS
concentration in all samples and the original culture filtrate was determined by kinetic

67
turbidimetric LAL assay (Charles River Labs). The detection limit of LPS concentration
in solution was 0.1 EU/ml.

Fluorescent imaging
Fluorescent-labeled LPS conjugate (AlexaFluor® 594 conjugate, Invitrogen) was
used to study the areas where LPS binding occurred throughout the membrane wall.
Prior studies have shown that a fluorescent label attached to the LPS molecule does not
affect the behavior of the LPS (31). Mini-modules (Fig. 4.2) were constructed for the
fluorescent imaging portion of the study, to reduce the amount of fluorescent-labeled LPS
conjugate required. Thirty fibers of each type were placed in a polycarbonate tube (15
cm in length, 2.4 mm inside diameter) and potted using UV-curable epoxy resin (Dymax
Corp.). Mini-modules were subjected to the same experimental simulation setup as the
other membranes, with 60 minutes of diffusive and 60 minutes of convective testing.
However, fluorescent-labeled LPS was used to contaminate the dialysate. Each minimodule was subjected to a challenge of 800 EU/ml of labeled LPS conjugate, with the
simulation run in a controlled dark environment. Flow rates used with the mini-modules
similar in proportion to the larger dialyzers: 1 ml/min for the BC, 2 ml/min for the DC.
After the simulations were complete, mini-modules were placed in a drying oven
overnight to prepare for sectioning and imaging. The process of embedding, slicing and
imaging the samples used a previously described protocol modified for this study (2, 32).
Fiber membranes were removed from their housings and sectioned to 10 μm using tissue
freezing media (Triangle Biomedical Sciences), a low-profile microtome blade (SEC 35e,
Richard-Allan Scientific) and a cryostat (Leica 1850, Leica Microsystems). Sectioned
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fibers were imaged using a fluorescence microscope (Nikon TE2000-S, Nikon Corp.)
with a Resorufin filter set (Chroma Technology). This filter set was used to minimize
membrane auto-fluorescence and maximize fluorescence of the AlexaFluor® 594
conjugate. Images of the membrane samples were obtained with a 12 megapixel camera
(Nikon DXM1200, Nikon Corp.) at a resolution of 1280 X 1024 using a 60-second image
integration time and analyzed with ACT-1 software (Nikon Corp.).

Fluorescence

intensity through the cross-section of each fiber was measured using ImageJ software
(National Institutes of Health).

FIG. 4.2. Mini-module used for fluorescence imaging, showing polycarbonate housing
and T‟s, with UV curable epoxy for potting material. Approximately 30 fibers, 15 cm in
length, provide the mini-module with about 15 cm2 of surface area.
Surface characterization by water contact angle
For all membranes tested, sessile drop contact angle analysis was performed on
both the outer surface and lumen of the fibers. To access the lumen, the fiber was cut
longitudinally and spread open onto double-sided tape. A goniometer (VCA Optima,
AST Products) was used to image 0.25 μl droplets of double-distilled water on the

surface.
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Immediately following the application of the droplet, a digital image was

captured; from this image the contact angle of the droplet was determined (n = 8).

SEM imaging
Fiber membranes were prepared for SEM by dipping the fibers in liquid nitrogen
and snapping them with a quick motion, yielding a 90o break. Membranes were then
placed onto an imaging stage and coated with gold to 20 nm thick using a sputter coater
(Lesker 108, Kurt J. Lesker Co.) and a thickness monitor (Cressington MTM10,
Cressington Scientific Instruments Ltd.). Membranes were then imaged using a field
emission scanning electron microscope (Hitachi F-4000, Hitachi, Ltd.).
RESULTS
Dialysis simulations using bacterial culture
filtrates as challenge material
Dialysis simulation data for all membranes tested are shown in Figs. 4.3-4.5, with
curves representing LPS levels measured from the blood compartment and dialysate
compartment. All plots use a semi-log scale for the LPS concentration. Maximum LPS
levels in the DC typically occurred from minute 7 to minute 15, attributed to the time
required for the LPS to equilibrate throughout the system. All graphs show a decrease in
free LPS in the DC with time due to adsorption to the membrane.
Initial LPS levels in the dialysate reservoirs measured by the LAL assay were as
follows: Optiflux, 455 ± 44 EU/ml; low-PVP, 446 ± 73 EU/ml; high-PVP, 410 ± 107
EU/ml; bleach, 467 ± 224 EU/ml; copolymer, 241 ± 43 EU/ml. During the dialysis
simulations no LPS was detected in the BC samples from the Optiflux membrane (Fig.
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FIG. 4.3. Semi-log plot of LPS concentrations in the DC (closed circle) and BC (open
circle) for Optiflux (control) membrane (mean ± s.d., n = 3).
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FIG. 4.4. Semi-log plot of LPS concentration in BC and DC of high-PVP and low-PVP
membranes (mean ± s.d., n = 3).
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FIG. 4.5. Semi-log plot of LPS concentration in BC and DC of bleached and PS-PEG
copolymer membranes (mean ± s.d., n = 3).
4.3), indicating any LPS back-filtrate was below 0.1 EU/ml. In contrast, LPS was
detected to varying degrees in the BC in all of the modified membranes following the
initial LPS challenge (Figs. 4.4-4.5). Maximum LPS BC concentrations occurred during
diffusive conditions for the low-PVP, high-PVP, and bleach treated membranes, whereas
LPS concentrations were highest during convective flow for the copolymer fibers. BC
peak LPS concentrations were as follows: low-PVP, 0.2 EU/ml @ 7 min.; high-PVP,
14.4 EU/ml @ 60 min.; bleached, 3.8 EU/ml @ 60 min.; copolymer, 24.8 EU/ml @ 67
min.

Surface hydrophobicity by contact angle analysis
Contact angle measurements were performed on both the outer and inner skin of
the fiber membrane. Results for the contact angle measurements are presented in Fig.
4.6, with mean ± standard deviation (n = 8). Statistical analysis showed significant
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FIG. 4.6. Contact angle measurements of both inner lumen and outside of fiber
membranes (mean ± s.d., n = 8). Statistical analysis revealed significant difference (p <
0.05) among all samples. Significant difference between the outside and lumen side
contact angle was found only in the copolymer and high-PVP membranes.
differences between outer surface and inner lumen contact angles and among the different
membrane types.

Results indicate that the copolymer and high-PVP membranes

exhibited significant differences between the outer and inner skin contact angles (p <
0.05). All lumen contact angles were significantly different from each other, while all
outside contact angles were significantly different except Optiflux and high-PVP
membranes. Differences in contact angle arise from physicochemical differences among
fibers, namely surface roughness, porosity, and concentration and location of the
hydrophilizing agent, PVP.

Imaging of dialysis membranes
Fluorescence and SEM images, as well as intensity profiles for all membranes
tested, are presented in Figs. 4.7-4.11, to illustrate LPS distribution, general membrane
geometry, morphologies of the membrane cross sections near the lumen and outside
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FIG. 4.7. Optiflux membrane: Fluorescence image (A), SEM images of the cross section
(B), near the lumen (C), and near the outer wall (D), and fluorescence intensity profile
(E). Fluorescent-labeled LPS conjugate is distributed throughout the entire membrane
cross-section, accumulating near the inner lumen surface. The intensity profile shows the
distribution of LPS adsorption from lumen (left) to outside (right). The arrow in Panel C
indicates the boundary of the lumen wall.
surfaces. The arrow in Panel C of Figs. 4.7-4.11 indicates the boundary of the lumen
wall.
As seen in the fluorescence microscopy images in Figs. 4.7-4.11, AlexaFluor-LPS
aggregated near the lumen for all fibers except the PS-PEG copolymer, where a reverse
trend was observed.

The low-PVP membrane exhibited a higher LPS affinity as

indicated by overall image intensity and a more uniform distribution of LPS throughout
the fiber spongy matrix as compared to the other fibers. The presented images were
representative of all imaged samples (n ≥ 3 for each fiber type); no atypical fluorescent
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FIG. 4.8. Bleached fiber membrane: Fluorescence image (A), SEM images of the crosssection (B), near the lumen (C), and near the outer wall (D), and fluorescence intensity
profile (E). Fluorescence distribution and surface structure were similar to the Optiflux
membrane. The different structure in the bottom left of the fluorescence image is due to
cryostat cutting artifact.
patterns were observed. Intensity profiles (Panel E, Figs. 4.7-4.11) all show relative
fluorescence intensity through the cross section of the fiber from lumen (left) to outside
(right).
The cross-sectional SEM images in Figs. 4.7-4.11 show similar spongy
asymmetric matrix structures for the Optiflux, bleached, high-PVP, and low-PVP
membranes. For these membranes the lumen exhibited a less porous wall while the
outside structure was a highly porous polymer network. The copolymer membrane (Fig.
4.11) exhibited a “three-layer” structure with a spongy matrix in the outer half of the
membrane, a macroporous structure in the inner half, and a molecular weight cut-off
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FIG. 4.9. High-PVP membrane: Fluorescence image (A), SEM images of the crosssection (B), near the lumen (C), and near the outer wall (D), and fluorescence intensity
profile (E). Fluorescence intensity for the matrix portion of the membrane is much lower
for this sample compared to the other samples indicating less adsorption of LPS.
region near the lumen. Fig. 4.11 reveals macropores extending to the inner wall of the
membrane as well as a less porous exterior wall. A clear demarcation in the transition
from macropores to spongy matrix is seen in Fig. 4.11B. The difference in the structure
of this membrane can be attributed to distinct thermodynamics of the phase inversion
arising from the use of the PS-PEG copolymer as compared to PVP.
AFM and SEM images of the lumen and outside surfaces are presented in Figs.
B.1-B.5 (Appendix B). RMS values for presented AFM images are shown in Table B.1
(Appendix B), with a discussion of such in Appendix B.
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FIG. 4.10. Low-PVP fiber membrane: Fluorescence image (A), SEM images of the
cross-section (B), near the lumen (C), and near the outer wall (D), and fluorescence
intensity profile (E). Distribution of LPS for this membrane is similar to the Optiflux
membrane. However, intensity is much stronger here indicating a higher affinity of the
LPS to the membrane.
DISCUSSION
Much attention has recently been given not only to the quality of dialysis water,
but to using the dialyzer as a mechanism to prevent back-filtration of bacterial LPS. This
study focused on the latter, with attention to investigating how chemical changes in the
filter membranes cause LPS to preferentially bind to certain areas and in what quantities.
While studies have shown that incidents of pyrogenic reactions are fairly low, the
possibility of back-diffusion of bacterial fragments should be considered great due to the
difficulty of detecting and removing biofilms in water purification systems, as previously
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FIG. 4.11. PS-PEG Copolymer fiber membrane: Fluorescence image (A), SEM images
of the cross-section (B), near the lumen (C), and near the outer wall (D), and fluorescence
intensity profile (E). In contrast to the other fiber types, a distinct transition in the
porosity of the spongy matrix is observed and LPS is restricted to the outer surface.
discussed. Should a large portion of one of these biofilms become dislodged, the increase
in LPS levels in dialysate could be dramatic. In this study, high concentrations of LPS
(roughly 20 times the allowable amount for medical devices) were used to show the
ability of hollow fiber membranes to adsorb and filter LPS from solution and to represent
a “worst case scenario.”

However, because experiments were performed at

concentrations well below the critical aggregation concentration of LPS similar trends in
LPS backfiltration and adsorption would be expected exist at lower concentrations (33,
34).
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Results from the high- and low-PVP simulations (Fig. 4.4) show increases in LPS
back-diffusion compared to the Optiflux (control) membrane, especially under diffusive
conditions. The low-PVP membrane also adsorbed more LPS through the diffusive
portion of the simulation, as observed by the sharp decrease in LPS concentration in the
dialysate compartment and bright intensity in the corresponding fluorescence image. It is
noted that the LPS levels in the blood compartment decreased with time during diffusive
conditions and immediately dropped below the detection limit during convective
conditions for the low-PVP membrane. This decrease in BC LPS levels during diffusive
conditions suggests that LPS in the BC may have adsorbed to the membrane or reentered
the dialysis circuit solution. During convective flow all LPS is likely adsorbed or forced
into fiber pores. The high-PVP membrane allowed the most LPS transfer into the BC
compared to all other membranes. SEM images show a thicker wall structure for the
high-PVP membrane (46 μm) than all others (< 38 μm), demonstrating that wall
thickness does not necessarily contribute to preventing LPS back-diffusion.
It has been shown previously that dialyzers reprocessed using Renalin® (a
sterilant composed of hydrogen peroxide, peracetic acid, acetic acid, and water) resisted
trans-membrane passage of LPS during treatments (35). Similarly, polysulfone dialyzers
subjected to 13 volumes of a bleach solution were able to remove endotoxin from a
challenge solution (36). Bleached membranes in this study allowed LPS back-diffusion
immediately upon commencement of the diffusive simulation, but less under convective
conditions. This confirms other findings that solute transport characteristics are greatly
dependent on the dialyzer being studied and the reprocessing technique (29, 37).

PEG is often added to surfaces as a protein-repellant layer (38).
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PS-PEG

copolymers have previously been incorporated into PS filter membranes to repel proteins
and to enhance surface wettability (39-40). PS-PEG copolymer was investigated here for
its ability to repel bacterial LPS challenges. The fluorescence, SEM, and contact angle
data indicate that during coagulation of the spin-mass a unique three-layer structure
formed that readily bound LPS, but restricted adsorption to the outer spongy portion of
the membrane. Back-diffusion of LPS, however, was observed after minute 7 of the
diffusive simulation.

Under convective conditions the membrane allowed a greater

diffusion of LPS to the BC, while also adsorbing most of the LPS in the challenge
solution as noted by the decrease in DC LPS concentration. It is observed that the LPS
concentration in the BC remained at or near the detection limit for most of the diffusive
conditions for the copolymer membrane, then increased to about 0.4 EU/ml by 60 min.
In contrast to the other membranes, the BC LPS concentration increased upon switching
to convective conditions for the copolymer fiber. It is also seen in the SEM cross-section
that the spongy matrix pores in the copolymer fiber are much smaller near the outer wall,
which may prevent the transport of LPS into the BC during diffusive conditions. These
scenarios are being addressed in ongoing work where fiber cross-sections are examined
using SEM and fluorescence microscopy after diffusive and convective conditions.
Previous studies have shown that hollow fibers have a great capacity to remove
LPS from solution during dialysis simulations (1, 41). The average reduction in LPS
from the DC for all membranes tested was 93.7%, similar to previous studies (1). Of
note is the continual decrease in LPS concentration (based on negative slope of the
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simulation data at minute 120) in the DC for all membrane types, indicating that all
membranes had not reached their adsorptive capacities for LPS.
To address the distribution of PVP and PEG we employed water contact angle
analysis of fiber lumens and outside walls (Fig. 4.6). PVP, a common additive to PS
membranes, is used to decrease hydrophobicity, increase biocompatibility, and create
pores during the phase inversion process (42). The water contact angles for lumen and
outer wall for the Optiflux membrane were 48 and 47, respectively, similar to values
previously reported (1). The addition or reduction of PVP concentration is reflected in
the lower and higher contact angles for the high- and low-PVP membranes, respectively,
compared to the Optiflux standard. Bleaching of PS-PVP membranes has been shown to
cause an increase in hydrophobicity and net negative charge, attributed to chain scission
of PVP via radical reactions (35, 43-45).

Bleaching Optiflux fibers for 2 minutes

increased hydrophobicity as shown in the increase in contact angle.
Unlike PVP, the PS-PEG additive is an amphiphilic copolymer, which will
influence phase separation during the fiber precipitation process, as suggested by the “3layer” structure observed in the SEM cross-section. The higher contact angles observed
for the PS-PEG membrane are indicative of more hydrophobic domains (likely due to
hydrophobic polysulfone) on these surfaces. It is possible that the PEG chains are
sequestered in the fiber matrix while PS is concentrated at the interfaces (outside wall and
lumen), thus causing an increase in contact angle of these surfaces, and subsequently less
LPS adsorption through the spongy matrix. The increase in outside membrane contact
angle is different than a previous study that suggested that PEG chains segregated to the
outside surfaces of the membrane causing a more hydrophilic membrane (39-40).
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However, due to the sensitive nature of the phase inversion process, small changes can
dramatically alter thermodynamic partitioning of the polymers in the spin-mass (27).
Continuing research will focus on varying ratios of PS:PEG and refining spinning
conditions to obtain a membrane structure more similar to the Optiflux fiber while
eliminating LPS entry into the BC and continuing to favor LPS adsorption to the outer
wall.
It has been shown that LPS preferentially binds to hydrophobic membranes and
that PVP restricts adsorption of proteins to PS membranes (42, 46). Therefore it would
be expected, based on contact angles, that the bleached, low-PVP, and copolymer
membranes would bind more LPS than the Optiflux control. Fluorescence images and
intensity profiles show that LPS bound extensively through the matrix of the low-PVP
membrane but only to the outside of the copolymer membrane. LPS also bound more
prevalently through the matrix of the bleached membrane compared to the Optiflux
membrane, suggesting a chemical makeup in the spongy matrix similar to the low-PVP
membrane. PVP content is likely diminished throughout the membrane as indicated by
the increase in contact angle compared to the Optiflux membrane. Also, LPS bound only
near the lumen of the more hydrophilic high-PVP membrane and not through the matrix
of the hollow fiber. SEM images for all membranes but the copolymer show a thick
lumen wall. It is likely that LPS in these membranes was trapped near the lumen because
of this wall structure. Conversely, the copolymer fiber had much larger macropores near
the lumen that likely allowed LPS to easily pass through to the BC.

Therefore,

adsorption of LPS is likely due to both hydrophobic interactions as well as physical
entrapment by pores.
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All modified membranes allowed some back-filtration of LPS in the simulation.
Because the copolymer membrane bound most LPS on the outer membrane it can be
inferred that LPS that breached the outer part of the copolymer membrane did not bind to
the matrix of the hollow fiber, rather it continued through to the BC. Restricting LPS
adsorption to the outside wall of the copolymer membrane is viewed as beneficial as it
has been shown that LPS does not need to be in direct contact with blood to elicit a
pyrogenic response (8). Although LPS was not detected in the BC of the Optiflux fiber,
the possibility of pyrogenic response is still of concern as LPS bound strongly near the
lumen and LPS may still exist in the BC below detection limits. Thus, the PS-PEG
copolymer formulation employed here is very intriguing as it may afford a means to
restrict LPS to the outer membrane.
CONCLUSION
The evolution toward high-flux dialysis membranes coupled with bicarbonate
dialysate in hemodialysis necessitates validation of these membranes as pyrogen
adsorbers and/or filters. It is important to assess chemical properties of membranes that
specifically adsorb and prevent back-filtration of LPS into the BC of dialyzers. Also, it is
of interest to determine the effect of reprocessing on LPS back-filtration and adsorption
characteristics.
It has been shown in this study that the chemical means by which dialysis
membranes adsorb and filter LPS from contaminated dialysate can be tuned through
hydrophobic interactions.

It has also been shown that bleach treatments at low

concentration and short exposure time can cause dramatic changes in back-filtration and
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surface physicochemistry of dialysis membranes. Furthermore, it was shown that the
addition of PS-PEG to PS caused changes in membrane porosity, surface chemistry, and
LPS adsorption characteristics.

Of most importance with the PS-PEG copolymer

membrane was the ability of the membrane to adsorb LPS primarily on the outside of the
membrane, reducing the possibility of pyrogenic reactions with blood.
From these studies it is clear that LPS can be trapped selectively at fiber lumens
or outer walls through minor modifications in the PVP content of the spin mass as well as
through addition of PS-PEG copolymer. Mixtures of PVP with the copolymer are also of
interest as this may allow us to more specifically tune surface properties as well as
optimize the morphology of the spongy matrix to selectively trap LPS at the outside wall
without allowing any LPS to enter the BC as observed for all chemical modifications
presented here.
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CHAPTER 5
POLY-L-LYSINE AS SCAVENGER OF BACTERIAL ENDOTOXIN:
CHARACTERIZATION OF SOLUTIONS AND APPLICATION
ABSTRACT:

The removal of bacterial endotoxin (lipopolysaccharide, LPS) from

solutions is an important step in the purification of biological products and the prevention
of pyrogenic reactions during hemodialysis treatment.

This study focused on

characterizing the interactions of LPS and poly-L-lysine (PLL) in solutions and using
these interactions to bind LPS to PLL-modified polymer membranes. Interactions were
described using surface tension measurement of solutions and particle size analysis by
dynamic light scattering.

Atomic force microscopy (AFM) was used to describe

interactions on mica and modified glass. Polymer membranes modified with PLL were
subjected to fluorescent-labeled LPS to characterize the adsorption capacities of these
modified membranes. PLL caused both a decrease in surface tension of LPS solutions
and an increase in solution particle size, with a critical PLL to LPS ratio of 1:1. AFM of
hydrophobic and hydrophilic surfaces touched to the air-water interface of solutions
containing LPS and PLL revealed large aggregates and strands that increased in size with
increasing PLL concentration. Fluorescence microscopy revealed that aggregates of PLL
and LPS prevented adsorption to PLL-modified membranes. Also, membranes modified
with 1 μg/ml of uncross-linked PLL bound LPS in similar quantities as membranes
modified with 100 μg/ml of cross-linked PLL.

89
INTRODUCTION
The removal of bacterial endotoxin (lipopolysaccharide, LPS) from solutions has
become an important topic not only in the production of biological solutions, but in the
prevention of LPS transfer during hemodialysis treatments (1-4). Novel chemistries and
geometries are being sought to preferentially adsorb LPS to membranes while restricting
adsorption of other solution components. Characterizing the interaction of LPS with
chemical adsorbents is critical to understanding adsorption properties and optimizing
removal methods.
Bacterial endotoxin is a surface-recognition constituent of gram-negative bacterial
membranes consisting of three main parts: an outer-membrane-integrated lipid (lipid A),
a core oligosaccharide, and a long heteropolysaccharide chain (O-antigen) (5). The Oantigen varies among different bacterial strains and is the recognition site for blood-borne
antibodies. The lipid A portion is generally conserved among bacterial types and is
responsible for causing pyrogenic reactions. LPS is an amphiphilic molecule that has
been shown to preferentially adsorb to hydrophobic surfaces (6). However, the netnegative charge due to the phosphate groups on the lipid A portion also make it
susceptible to binding with affinity sorbents (7).
Removal of LPS from solution is generally achieved using affinity sorbents and
filtration. Plasma exchange and charcoal hemoperfusion, as well as immobilization to
polymyxin B, ceramic membranes, and functionalized nanoparticles, have been
investigated with varying degrees of success (8-12). Polycations, more specifically polyL-lysine (PLL), have been used in conjunction with filtration membranes and
chromatography columns to remove LPS from solutions (13-15).

However, other
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chemistries, such as diethylaminoethane, histamine, and histidine have also been shown
to be effective LPS adsorbents (13). Cationic polyelectrolytes presumably bind to the
negatively-charged phosphate groups on LPS.
LPS solutions exhibit certain characteristics that have been studied through
numerous methods including dynamic light scattering, fluorescence microscopy, atomic
force microscopy, fluorescence spectroscopy, and Langmuir isotherm measurements (1620). The amphiphilic nature of LPS causes it to form micelles and larger aggregates in
solution comprised of up to 49 molecules with sizes ranging from 14-300 nm in diameter
(16, 21).
The present study aims to introduce surface tension measurement as a new
method of characterizing LPS solutions. We also characterize the interaction of LPS and
PLL solutions using surface tension measurement, dynamic light scattering, and describe
macromolecular interactions based on atomic force microscopy. These interactions of
LPS and PLL are used to adsorb LPS to membranes modified with PLL and show that
membranes with many available amino groups bind large amounts of LPS from a
circulating solution.
MATERIALS AND METHODS
Solutions
LPS from Escherichia coli 055:B5 (Sigma-Aldrich) and PLL (70-150 kDa MW,
Sigma-Adrich) were dissolved in 10 mM PBS (Perbio) containing 0.14 M NaCl and 0.01
M KCl at pH 7.4. Solutions were mixed at various concentrations and used without

91
further purification for all tests except particle size analysis using DLS, where solutions
were filtered using a 0.45 μm filter.

Surface tension measurement
Surface tension measurements of solutions containing LPS, PLL, and mixtures of
the two substances were performed on a tensiometer, μtrough S (Kibron, Inc.). Solutions
were dispensed in 1-inch diameter Teflon-coated wells and allowed to equilibrate for 20
minutes prior to measuring. Measurements (n = 9) were made at 25oC and 24% relative
humidity.

Particle size with dynamic light scattering
Particle sizes of LPS and PLL in solution were obtained using a Brookhaven BI200SM goniometer and BI-9000AT digital correlator.

Measurements (n = 3) were

conducted at a fixed 90o angle, at room temperature, and at a wavelength of 633 nm. The
averaging time during the measurement of the correlation function was 2 minutes. Size
distributions were determined from the experimental data using the NNLS algorithm in
the BIC software (Brookhaven Instruments Corp.) and expressed as hydrodynamic
diameter in nm.

Atomic force microscopy of solutions on mica
and OTS-modified glass
Solutions of LPS, PLL, and mixtures of the two substances were prepared
according

to

the

method

used

to

obtain

surface

tension

measurements.

Octadecyltrichlorosilane (OTS)-modified glass cover slips were prepared according to
the method described previously (22). Clean mica or OTS-coated glass was gently
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touched to the air-water interface and peeled from the surface as to avoid removing large
amounts of the solution. Samples were dried prior to imaging with AFM.
Sample surface morphology was observed using a Bioscope AFM (Nanoscope
IIIa, Digital Instruments, Inc.) in tapping mode with a silicon nitride cantilever (40 N/m,
Tap300, Budget Sensors). Samples (n = 3) were imaged at 2 x 2 μm 2. Analysis of
sample features was performed using Nanoscope III imaging software (version 5.30r3,
Digital Instruments, Inc.). Fig E.2 contains representative images of profile cuts used to
determine feature sizes.

Fluorescence studies
Polymer hollow fiber mini-modules (Fig. 5.1) were constructed by placing 30
Fresenius Optiflux® F200NRe membranes (Fresenius Medical Care North America),
polysulfone membranes sterilized via electron beam, in a polycarbonate tube (15 cm in
length, 2.4 mm inside diameter) and potted using UV-curable resin (Dymax Corp.).
Optiflux® fibers were chosen based on their effective pore size, selectively limiting
filtration at approximately 60 kD.
Fibers were coated with PLL and challenged with LPS according to the setup in
Fig. 5.2. PLL coating solutions were prepared by mixing PLL (70-150 kDa MW, SigmaAldrich) in endotoxin-free water (ThermoFisher Scientific, Inc.). Tubing was rinsed
using DDI water for 10 minutes prior to and between all coatings. Modules were coated
for 60 minutes at 44 ml/min. Several modules were then subject to 2.5% glutaraldehyde
(GA, Fisher Scientific Co.) in PBS from the outside for 20 minutes to cross-link the PLL
to the membranes. Finally all fibers were rinsed with several volumes of 1 M NaCl to
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FIG. 5.1. Mini-module showing polycarbonate housing and T‟s, with UV curable epoxy
for potting material. Approximately 30 fibers, 15 cm in length, provide the mini-module
with about 15 cm2 of surface area.

44 ml/min

PLL or LPS
solution

Outside
Lumen

FIG. 5.2. Experimental setup for PLL coatings and LPS challenge tests. Fibers were first
coated for 60 minutes with PLL, dried overnight in an oven, and then challenged with
LPS for 60 minutes.
remove all unbound PLL and GA, evacuated of fluid, and placed in an oven overnight at
70oC.
Fluorescent-labeled LPS conjugate (AlexaFluor® 594 conjugate, Invitrogen) was
used to study the areas where LPS binding occurs throughout the membrane wall. Prior
studies have shown that a fluorescent label attached to the LPS molecule does not affect
the behavior of the LPS (23). The dialyzers were challenged similar to the PLL-coating
procedure. Each module was subjected to a challenge of 100 ng/ml of labeled LPS
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conjugate and varying concentrations of PLL, in endotoxin-free water, with the
simulation run in a controlled dark environment.
After the simulations were complete, mini-modules were placed in a drying oven
overnight to prepare for sectioning and imaging. The process of embedding, slicing, and
imaging the samples used a previously described protocol modified for this study (4, 24).
Fiber membranes were removed from their housings and sectioned to 10 μm using tissue
freezing media (Triangle Biomedical Sciences), a low-profile microtome blade (SEC 35e,
Richard-Allan Scientific) and a cryostat (Leica 1850). Sectioned fibers were imaged
using fluorescence microscopy (Nikon TE2000-S, Nikon Corp.) with a Resorufin filter
set (Chroma Technology).

This filter set was used to minimize membrane auto-

fluorescence and maximize fluorescence of the AlexaFluor® 594 conjugate. Images of
the membrane samples were obtained with a 12 megapixel camera (Nikon DXM1200,
Nikon Corp.) at a resolution of 1280 X 1024 using a 60-second image integration time
and analyzed with ACT-1 software (Nikon Corp.). Fluorescence intensity analysis was
performed using ImageJ software (National Institutes of Health).
RESULTS
Surface tension of solutions
Surface tensions of solutions containing LPS, PLL, and mixtures of the two
substances were performed to determine molecular interactions at the air-water interface.
Results for measurements of LPS solutions are presented in Fig. 5.3.

Solutions

containing up to 10 μg/ml LPS behaved similar to that of the PBS solution. From 101000 μg/ml LPS, surface tensions dropped logarithmically, thereafter reaching a lower
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FIG. 5.3. Semi-log plot of LPS surface tension of LPS in PBS (mean ± s.d., n = 3),
including best curve fits for upper (below 10 μg/ml LPS) and lower (above 1000 μg/ml
LPS) plateaus and logarithmic drop (between 10 and 1000 μg/ml LPS).
plateau of approximately 38 mN/m. At the transition points at both lower and upper
extremes, there tended to be a larger variation in surface tension.
Surface tensions of solutions containing LPS and PLL are displayed in Fig. 5.4.
PLL was added to LPS to produce solutions containing 47.5 μg/ml of LPS and PLL
concentrations of 0.05, 0.5, 5, 50, and 500 μg/ml. It was observed that PLL in PBS
(concentrations in PBS ranging from 0.05 μg/ml to 500 μg/ml) did not alter surface
tension from that of PBS (data not shown). PLL at low concentrations (≤ 5 μg/ml) did
not alter surface tension from that of the LPS solution, while PLL at higher
concentrations (from 50 μg/ml) caused a significant drop in surface tension of the LPS
solution.
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FIG. 5.4. Semi-log plot of surface tensions (mean ± s.d., n = 9) and hydrodynamic
diameters (mean ± s.d., n = 3) of solutions containing PLL in 47.5 μg/ml LPS. Surface
tension and particle size both showed a transition point between 5 and 50 μg/ml PLL in
LPS. Solutions containing PLL only did not alter surface tension from that of PBS (data
not shown). Also, solutions containing PLL only did not produce meaningful particle
sizes up to 1 mg/ml (data not shown).
Particle sizes from DLS measurements
Particle sizes of solutions containing PLL, LPS, and mixtures of the two
substances were measured to determine molecular interactions in solution. While PLL in
PBS did not produce meaningful particle sizes up to 1 mg/ml, solutions containing 10,
50, and 100 μg/ml LPS yielded particles with hydrodynamic diameters averaging 65.4 ±
6.9 nm for all solutions. Solutions below these concentrations were too dilute to yield an
accurate measurement.
Particle sizes for solutions containing both PLL and LPS are presented in Fig. 5.4.
Mixtures containing 0.5 and 5 μg/ml PLL yielded similar particle sizes with
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hydrodynamic diameters near 110 nm, while particles for mixtures containing 50 μg/ml
PLL were approximately 3 times larger. This transition point corresponds with the
transition point for surface tension measurements indicating changes in interaction both
in solution and at the air-water interface at this PLL:LPS ratio.

AFM of LPS and PLL solutions on mica
and OTS-modified glass
AFM was used to visualize interactions of LPS and PLL pulled from the air-water
interface of solutions using mica and OTS-modified glass. Representative images from
these tests are shown in Figs. 5.5 and 5.6. Samples from solutions containing 1 and 10
μg/ml LPS (Panels A and B, Fig. 5.5) exhibited salt clusters but no other surface features.
Samples from solutions containing 50 and 100 μg/ml LPS (Panels C and D, Fig. 5.5)
exhibited small “islands” approximately 0.5-1.3 nm in height. Higher concentrations of
LPS led to larger height features and increased overall size of the “islands” on the mica
surface. Tests were also performed by transferring films from the air-water interface of
LPS solutions to OTS-modified glass, but no changes in surface morphology were
observed for these samples (images not shown). Similarly, samples prepared using PLL
solutions did not yield any features on the mica surface (images not shown).
Samples from solutions containing both PLL and LPS yielded large features on
both mica (Fig. E.1, Appendix E)) and OTS-modified glass (Fig. 5.6).

The OTS-

modified glass itself exhibited small OTS “anchors,” hydrophobic domains formed in
preparing the surface of the glass, visible in Panel A of Fig. 5.6. These features were
approximately 80 nm in diameter and 6 nm in height. The samples prepared using 0.5
μg/ml PLL and 47.5 μg/ml LPS showed no features beyond that seen in native OTS-
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modified glass. The samples prepared using 5 and 50 μg/ml PLL, and 47.5 μg/ml LPS,
exhibited large strands, branching between the OTS anchors. These strands increased the
height of the OTS anchors to 10.1 ± 3.1 and 16.3 ± 2.9 nm for the 5 and 50 μg/ml PLL
samples, respectively.

Also, the diameter and height of the strands increased with

increasing PLL concentration as follows (n = 8): 25.4 ± 6.9 nm width, 1.5 ± 0.3 nm
height for 5 μg/ml PLL; 29.3 ± 5.5 nm width, 3.7 ± 1.2 nm height for 50 μg/ml PLL. The
orientation of the connections in Panels B and C in Fig. 5.6 is due to the method of
interface transfer and drying.

FIG. 5.5. AFM images of LPS on mica from solutions containing (A) 1 μg/ml, (B) 10
μg/ml, (C) 50 μg/ml, and (D) 100 μg/ml LPS in PBS. Solutions containing more than 10
μg/ml LPS led to images containing small “islands,” presumably LPS deposits on the
mica surface.
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FIG. 5.6. AFM images of LPS and PLL on OTS-modified glass from solutions
containing 47.5 μg/ml LPS and (A) 0.5 μg/ml PLL, (B) 5 μg/ml PLL, and (C) 50 μg/ml
PLL. OTS “anchors” allowed for LPS and PLL to form organized strands on surface.
Increasing PLL concentration led to larger surface features.
Fluorescence studies
Fluorescence images of several challenged membranes are shown in Fig. 5.7.
Membranes not subject to PLL or LPS were sectioned and imaged to view the
background fluorescence due to the polymer membranes (Panel A, Fig. 5.7). Membranes
coated with PLL and challenged with fluorescent-labeled LPS are presented in Panels BD of Fig. 5.7. Membranes coated with PLL, cross-linked with GA, and challenged with
fluorescent-labeled LPS are presented in Panels E-G of Fig. 5.7. Presented images are
representative of all membranes imaged for each sample. Fluorescence intensities for all
membranes challenged with LPS are presented in Fig. 5.8, with the background
fluorescence subtracted from overall intensity values. It must be noted that fluorescence
is due solely to the LPS-conjugate and the polymer membranes; PLL did not contribute to
fluorescence using the filter set.
As can be seen in Fig. 5.8, membranes not coated with PLL bound LPS to some
degree. The membrane coated using 1 μg/ml PLL (Panel C, Fig. 5.7) bound more LPS
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than all other membranes not treated with GA, with fluorescence increasing from 2-5
times that of other membranes. Above this concentration of PLL, fluorescence intensity
dropped to levels similar to that of uncoated membranes. For membranes treated with
GA, fluorescence intensity increased with increasing PLL concentration, with that of the
membrane coated with 1000 μg/ml PLL increasing to 18 times the intensity of an
uncoated membrane.
The cross-sectional images in Fig. 5.7 also reveal binding of LPS throughout the
membrane, with LPS binding more preferentially to the lumen or outside surfaces in most
samples. This observation plays a critical role in determining binding characteristics of
LPS and PLL as will be discussed.

FIG. 5.7. Fluorescence images of polymer hollow fibers modified with PLL and
challenged with fluorescent-labeled LPS. (A) Native-unchallenged hollow fiber used to
show background fluorescence of polymer membrane. Polymer hollow fibers coated
with PLL using (B) 0.1 μg/ml, (C) 1 μg/ml, and (D) 1000 μg/ml PLL. Polymer hollow
fibers coated with PLL and cross-linked using GA at PLL concentrations of (E) 0.1
μg/ml, (F) 1 μg/ml, and (G) 1000 μg/ml. Fig. D.1. (Appendix D) contains images of all
samples tested.

101
60

Relative Fluorescence Intensity

50
PLL
40

X-linked PLL

30

20

10

0
0

0.1

1

10

100

1000

PLL Coating Concentration (µg/ml)

FIG. 5.8. Relative fluorescence intensities of cross-sectional images of hollow fiber
membranes (mean ± s.d., n ≥ 3). Background fluorescence due to the membrane has
been subtracted from the presented values. Statistical analysis reveals significant
difference between the 1 μg/ml PLL only sample and all other PLL samples. Among the
cross-linked samples, 10, 100, and 1000 μg/ml PLL were all significantly brighter than
lower PLL concentrations.
Several membranes coated with 1 µg/ml were also subjected to a challenge
solution containing 100 ng/ml of fluorescent-labeled LPS and varying concentrations of
PLL.

Fluorescence images of these membranes are shown in Fig. 5.9.

Relative

fluorescence intensities of each membrane, standardized against membranes not
challenged with LPS, were as follows: 0 ng/ml PLL, 25.2 ± 0.6; 10 ng/ml PLL, 27.1 ±
3.7; 100 ng/ml PLL, 6.7 ± 0.2; 1000 ng/ml PLL, 8.6 ± 1.2.
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FIG. 5.9. Fluorescence images of polymer hollow fibers modified using a solution
containing 1 µg/ml PLL and challenged with solutions containing 100 ng/ml of
fluorescent-labeled LPS and (A) 0 ng/ml, (B) 10 ng/ml, (C) 100 ng/ml, and (D) 1000
ng/ml PLL.
DISCUSSION
While numerous methods to remove LPS from solutions exist, few methods have
characterized the interactions of LPS with adsorbents. Insights into these interactions can
help improve adsorption methods by directing researchers to using materials with
appropriate characteristics. This study focused on characterizing the interactions of LPS
and PLL and utilizing these interactions to remove LPS from solutions through the use of
PLL-modified polymer membranes.
In order to understand the interactions of PLL and LPS in solution, the dynamics
of LPS aggregation in solution and on surfaces were quantified.

Surface tension

measurement and hydrodynamic diameter quantization were performed on LPS solutions.
It was found that solutions of LPS have a surface tension similar to that of water (72
mN/m) up to about 10 μg/ml, whereupon surface tension dropped logarithmically up to a
concentration of about 1 mg/ml (38 mN/m). It has been proposed that aggregation of
LPS molecules is a continuous process starting at 10 μg/ml and proceeding up to 300
μg/ml, with critical aggregation concentrations to be between 1 and 38 μg/ml (16, 18-19,
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21). Surface tensions measured here begin dropping at or near the critical aggregation
concentration, forcing aggregates to the air-water interface, and continue until the
interface becomes saturated.
Particle sizes of LPS solutions, as measured using dynamic light scattering, have
been found to vary in size from 26 nm to 190 nm, with little effect due to solution
concentration (16, 19).

LPS solutions measured in this study were found to be

approximately 65 nm with no significant difference over a ten-fold increase in LPS
concentration. Particles in LPS solutions above the critical aggregation concentration,
then, remain the same size regardless of increased concentration.
Previous studies have shown that LPS preferably binds to hydrophobic surfaces
(6, 25). Findings in this study, however, showed that LPS did not bind to hydrophobic
OTS-modified glass but did bind to hydrophilic mica.

LPS particles measured by

dropping LPS solutions on mica at 40 μg/ml have been found to be 19.3 nm in diameter
and 1.2 nm in height (24). LPS aggregates on mica observed here using AFM were
found to mirror trends seen in surface tension tests; features on mica appeared, starting at
50 μg/ml, with height and diameter of features increasing with increasing concentration.
Additionally, the sizes of the “islands” observed in this study were much larger than
those previously observed. Higher LPS concentrations at the air-water interface, as
observed with surface tension measurements, may have allowed more LPS transfer to the
mica surface, leading to large surface features.
Aggregates of PLL and LPS were observed using surface tension, particle size,
and AFM. Measurements showed that increasing concentration ratios of PLL and LPS to
1:1 caused a significant decrease in surface tension and an increase in hydrodynamic
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diameter. This finding is contrary to previous reports that cationic antibiotics caused an
increase in surface tension of LPS monolayers, presumably taking LPS from the surface
and pulling it back into solution (26).

However, different scavengers, including

polyelectrolytes, proteins, and surfactants, may cause varying effects on LPS solutions (7,
27-30). The decrease in surface tension upon increasing concentration of PLL observed
here may have forced more LPS to the air-water interface, causing the solution to appear
to contain more LPS. DLS measurements showed that PLL caused LPS aggregation,
possibly forming clusters of aggregates or increasing aggregate size.
AFM images revealed strands of LPS and PLL on both mica and OTS-modified
glass. The OTS-modified glass contained clusters of polymerized OTS on the film
surface formed during the coating procedure, similar to those observed previously (31).
The hydrophobic clusters formed by OTS were used in hopes of providing “anchors” on
which the lipid tails of LPS would preferentially adsorb. The observed strands of LPS
and PLL are formed by electrostatic interactions, while hydrophobic interactions allowed
adsorption to the OTS. The lack of features in images of PLL or LPS on OTS-modified
glass further verifies that these electrostatic interactions give stability to the aggregates of
LPS and PLL.
Fluorescent-labeled LPS was used to visualize the distribution of LPS in polymer
hollow fiber membranes modified with different amounts of PLL. Similar membranes
have been shown to be slightly hydrophilic, with water contact angles of approximately
48o (3). It is interesting to note that images of samples modified with PLL using no
cross-linking agent showed the most fluorescence in the sample modified using 1 μg/ml
PLL. Images of membranes modified with 1 μg/ml PLL using no cross-linking agent and
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subject to LPS solutions containing varying concentrations revealed that at a PLL to LPS
ratio of 1:1, adsorption of LPS dropped dramatically. The aggregates of LPS and PLL
formed in solution prevented LPS adsorption to the membrane in these samples.
Similarly, for those membranes modified with PLL and subjected to LPS challenges, LPS
formed aggregates with the PLL molecules, releasing the PLL from the membrane.
The observations seen in DLS and surface tension measurements, as well as
images of LPS and PLL on OTS-modified glass and PLL-modified membranes show that
the 1:1 ratio of PLL to LPS is of great significance. While the PLL molecules contain
between 550 and 1170 phosphate groups, the LPS molecules contain only approximately
7 phosphate groups. Aggregates may be formed similar to a micellar structure, with lipid
A tails toward the center of the molecule, and saccharide chains and PLL molecules
organized on the outside. The binding of LPS to PLL may sterically hinder further
binding of PLL to the LPS molecules. It must also be noted that the concentrations used
in the modification and challenging of polymer membranes were much lower than those
used in surface tension and DLS measurements, indicating that the 1:1 ratio holds
significant value over a wide concentration range.
For cross-linked samples, increased concentrations of PLL led to increased LPS
adsorption. PLL was bound more tightly to the membrane due to the cross-linking,
however, binding sites were likely taken up by the cross-linking procedure as well. PLL
may have bound to the membrane only, or cross-linking may have caused larger
aggregates of PLL to form in membrane pores, preventing the release of PLL into the
solution upon LPS adsorption.
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Analysis of fluorescence images revealed that membranes modified using 1 μg/ml
PLL, with no cross-linking agent, adsorbed as much LPS as membranes modified using
10 and 100 μg/ml PLL with GA. PLL binding sites were likely compromised during the
cross-linking procedure as discussed, effectively lowering the number of available amine
groups for LPS adsorption. This observation suggests that lower concentrations of PLL
may be used to bind similar amounts of LPS, as long as binding sites on PLL are not
compromised.
Fluorescence images also reveal binding of LPS in larger quantities to the lumen
and outside of membranes. Because the setup shown in Fig. 5.2 did not include a
counter-current flow, diffusion of PLL and LPS throughout the membrane cross-section
would have been expected to be limited to the outside sections of the membrane. Larger
particle sizes of LPS formed in solution would have been limited in the depth of
penetration into the membrane. However, it is seen that LPS diffused readily to the inner
portion of the membrane where it bound in significant quantities in several membranes.
As seen in previous SEM images, the membrane has a tight molecular weight cutoff near
the lumen, where large aggregates of LPS and PLL molecules may have become
embedded in small pores (3). Also, larger aggregates of PLL and LPS formed in solution
may not have been able to penetrate the outermost layers of the membrane causing higher
fluorescence intensity at this boundary.
CONCLUSION
The present study focused on characterizing the aggregation behavior of LPS and
PLL in solution and using these interactions to bind LPS to polymer membranes modified
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with PLL. We have demonstrated that PLL binds LPS, forming aggregates both in
solution and on membrane surfaces. Aggregates formed in solution, causing a decrease
in solution surface tension and an increase in particle size as measured using DLS, were
found to begin at a PLL to LPS ratio of approximately 1:1. Features observed using
AFM increased in size with increasing PLL and LPS concentrations, forming stands of
aggregates up to 29.3 nm in width and 3.7 nm in height. The interactions of PLL and
LPS allowed for LPS adsorption on polymer membranes to varying degrees. Crosslinked PLL bound LPS to greater degrees with increasing concentrations. However,
membranes not subjected to cross-linking bound the most LPS using a lower
concentration of 1 μg/ml PLL.

Higher concentrations of PLL on the membrane

presumably bound LPS, forming large aggregates, then dissociated from the membrane.
It was also observed that membranes modified using uncross-linked PLL at 1 μg/ml
bound similar quantities of LPS as membranes coated with up to 100 μg/ml of crosslinked PLL. The widely used method of cross-linking PLL to membrane surfaces likely
compromises large numbers of LPS binding sites, rendering the membrane less adsorbent
toward LPS.
REFERENCES
1.

Petsch D, Anspach FB. Endotoxin removal from protein solutions. J Biotechnol
2000;76:97-119.

2.

Magalhães PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TCV, Jr. AP.
Methods of endotoxin removal from biological preparations: A review. J Pharm
Pharm Sci 2007;10:388-404.

3.

Henrie M, Ford C, Andersen M, Stroup E, Diaz-Buxo J, Madsen B, et al. In vitro
assessment of dialysis membrane as an endotoxin transfer barrier: Geometry,
morphology, and permeability. Artif Organs 2008;32:701-10.

4.

108
Hayama M, Miyasaka T, Mochizuki S, Asahara H, Yamamoto K-i, Kohori F, et
al. Optimum dialysis membrane for endotoxin blocking. J Membrane Sci
2003;219:15-25.

5.

Gorbet MB, Sefton MV. Endotoxin: The uninvited guest. Biomaterials
2005;26:6811-7.

6.

Takemoto Y, Nakatani T, Sugimura K, Yoshimura R, Tsuchida K. Endotoxin
adsorption of various dialysis membranes: In vitro study. Artif Organs
2003;27:1134-7.

7.

Anspach FB. Endotoxin removal by affinity sorbents. J Biochem Bioph Meth
2001;49:665-81.

8.

Linnenweber S, Lonnemann G. Pyrogen retention by the Asahi APS-650
polysulfone dialyzer during in vitro dialysis with whole human donor blood.
ASAIO J 2000;46:444-7.

9.

Bender H, Pflänzel A, Saunders N, Czermak P, Catapano G, Vienken J.
Membranes for endotoxin removal from dialysate: Considerations on feasibility
of commercial ceramic membranes. Artif Organs 2000;24:826-9.

10.

Darkow R, Groth T, Albrecht W, Lützow K, Paul D. Functionalized nanoparticles
for endotoxin binding in aqueous solutions. Biomaterials 1999;20:1277-83.

11.

Tetta C, Bellomo R, Inguaaggiato R, Wratten ML, Ronco C. Endotoxin and
cytokine removal in sepsis. Therap Apher Dial 2002;6:109-15.

12.

Sato T, Shoji H, Koga N. Endotoxin adsorption by polymyxin B immobilized
fiber column in patients with systemic inflammatory response syndrome. Therap
Apher Dial 2003;7:252-8.

13.

Anspach FB, Hilbeck O. Removal of endotoxins by affinity sorbents. J
Chromatogr A 1995;711:81-92.

14.

Petsch D, Beeskow TC, Anspach FB, Deckwer W-D. Membrane adsorbers for
selective removal of bacterial endotoxin. J Chromatogr B 1997;693:79-91.

15.

Hirayama C, Sakata M, Nakamura M, Ihara H, Kunitake M, Todokoro M.
Preparation of poly(ε-lysine) adsorbents and application to selective removal of
lipopolysaccharides. J Chromatogr B 1999;721:187-95.

16.

Bergstrand A, Svanberg C, Langton M, Nyden M. Aggregation behavior and size
of lipopolysaccharide from Escherichia coli O55:B5. Colloid Surface B
2006;40:99-106.

17.

109
Roes S, Seydel U, Gutsmann T. Probing the properties of lipopolysaccharide
monolayers and their interaction with the antimicrobial peptide polymyxin B by
atomic force microscopy. Langmuir 2005;21:6970-8.

18.

Aurell CA, Wistrom AO. Critical aggregation concentrations of gram-negative
bacterial lipopolysaccharides (LPS). Biochem Biophys Res Commun
1998;253:119-23.

19.

Santos NC, Silva AC, Castanho MARB, Martins-Silva J, Saldanha C. Evaluation
of lipopolysaccharie aggregation by light scattering spectroscopy. ChemBioChem
2003;4:96-100.

20.

Abraham T, Schooling SR, Beveridge TJ, Katsaras J. Monolayer film behavior of
lipopolysaccharide from Pseudomonas aeruginosa at the air-water interface.
Biomacromolecules 2008;9:2799-804.

21.

Yu L, Tan M, Ho B, Ding JL, Wohland T. Determination of critical micelle
concentrations and aggregation numbers by fluorescence correlation
spectroscopy:
Aggregation of a lipopolysaccharide. Anal Chim Acta
2006;556:216-25.

22.

Dhruv H, Pepalla R, Taveras M, Britt DW. Protein insertion and patterning of
PEG bearing langmuir monolayers. Biotechnol Progr 2006;22:150-5.

23.

Levels JHM, Abraham PR, Ende Avd, Deventer SJHv. Distribution and kinetics
of lipoprotein-bound endotoxin. Infect Immun 2001;69:2821-8.

24.

Hayama M, Miyasaka T, Mochizuki S, Asahara H, Tsujioka K, Kohori F, et al.
Visualization of distribution of endotoxin trapped in an endotoxin-blocking
filtration membrane. J Membrane Sci 2002;210:45-53.

25.

Yamamoto C, Kim S-T. Endotoxin rejection by ultrafiltration through high-flux
hollow fiber filters. J Biomed Mater Res A 1996;32:467-71.

26.

Zhang L, Dhillon P, Yan H, Farmer S, Hancock REW. Interactions of bacterial
cationic peptide antibiotics with outer and cytoplasmic membranes of
Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000;44:3317-21.

27.

Bosshart H, Heinzelmann M. Targeting bacterial endotoxin: Two sides of a coin.
Ann NY Acad Sci 2007;1096:1-17.

28.

Petsch D, Rantze E, Anspach FB. Selective adsorption of endotoxin inside a
polycationic network of flat-sheet microfiltration membranes. J Mol Recognit
1998;11:222-30.

29.

110
II AJD, Brogden KA, Engen R. Enterobacter agglomerans lipopolysaccharideinduced changes in pulmonary surfactant as a factor in the pathogenesis of
byssinosis. J Clin Microbiol 1988;26:778-80.

30.

Schram V, Hall SB. Thermodynamic effects of the hydrophobic surfactant
proteins on the early adsorption of pulmonary surfactant. Biophys J
2001;81:1536-46.

31.

Kirkpatrick
R,
Muhlstein
CL.
Performance
octadecyltrichlorosilane coated borosilicate glass.
2007;353:2624-37.

and
durability of
J Non-Cryst Solids

111
CHAPTER 6
CONCLUSIONS AND FUTURE WORK
KEY FINDINGS
In this work, the modification of polymer hollow fiber membranes was discussed
as it related to physicochemical changes incurred during sterilization or reprocessing
techniques and the ability of the membranes to remove bacterial endotoxin from
solutions. The findings demonstrate dramatic and potentially unintended changes in the
physicochemical properties and, subsequently, the filtration abilities of these membranes.
The first investigation focused on physicochemical changes associated with
common gas, irradiation, and chemical sterilization processes. It was observed that ebeam sterilization causes a decrease in surface water contact angle, while altering the
physical structure of nodule aggregates located at the lumen of the fibers, compared to
the ETO sterilized membrane. Also, bleach sterilization did not alter water contact angle
from that of the ETO sterilized membrane, but did cause a morphological change similar
to the e-beam sterilized fibers. Additionally a new method of characterizing hollow fiber
membranes, that of water evaporation rate, was presented as a novel means of deducing
sorption characteristics. The results demonstrate that common sterilization methods may
inadvertently change membrane properties, which may be detrimental in filtration
applications, as well as provide simple post-fabrication methods to tune properties toward
specific applications such as cell culture and tissue engineering.
The second and third investigations focused on the removal of bacterial endotoxin
from solutions through the use of chemical modifications to the membrane. The second
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study focused on polymer chemistry, more specifically PVP content or the addition of
PEG, as it related to prevention of back-filtration of LPS during hemodialysis treatment.
It was found that hydrophobicity of the membrane plays an important role in membrane
adsorption capacity, but that slight changes in PVP content alter the ability of the
membrane to prevent back-filtration of LPS. LPS adsorbed strongly to all PS-PVP
membranes near the lumen of the fiber, while PS-PEG membranes adsorbed LPS
primarily on the outer surface. This observation could play a vital role in preventing LPS
transfer to the blood, as well as prevent any possible pyrogenic reaction during
hemodialysis treatment.
The third study focused on characterizing interactions of LPS and PLL, while
using these interactions to remove LPS from solutions using PS-PVP membranes
modified with PLL.

It was found that LPS forms large aggregates in solution,

independent of solution concentration, that lower the surface tension of solutions. The
addition of PLL to a solution caused aggregates to increase in size, with a critical PLL to
LPS ratio of 1:1.

This binding ratio was found to exist regardless of solution

concentration. Polymer hollow fiber membrane modified using PLL were found to
effectively remove LPS from solutions. The widely used method of cross-linking PLL to
membranes, however, was shown to reduce the ability of PLL to adsorb LPS, as lower
concentrations of uncross-linked PLL were found to adsorb similar amounts of LPS.
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FUTURE DIRECTIONS
Chemical modifications to filtration
membranes in other geometries
It was demonstrated in this dissertation that using PLL-modified polymer hollow
fiber membranes was an effective method of increasing the adsorption capacities of these
membranes. Numerous other geometries exist and have been tested for LPS removal in
the literature including Sepharose beads, ceramic membranes, chloromethyloxirane
polymer beads, polyether polymer alloy membranes, and flat sheet nylon microfiltration
membranes (1-5).
While these methods have been shown to be effective at removing large
percentages of LPS from solutions, much research is being directed at using tangential
flow microfiltration systems (6-7). Tangential flow microfiltration systems work by
forcing a liquid tangentially across a filtration membrane, whereupon small molecular
weight species are forced through the pores of the membrane. The rapid flow of solution
across the membrane prevents excess buildup of larger particles, lowering membrane
fouling. While the buildup of proteins on a membrane may not be of concern while
filtering water used in dialysate, it is paramount in removing LPS from biologically
prepared solutions. Modification of tangential flow filtration membranes using PLL may
improve the adsorption capacities of these membranes.

Selective removal of LPS from protein solutions
The removal of bacterial endotoxin from biologically prepared solutions, such as
those produced using bioprocessing, has been discussed. It was found in this dissertation
that membranes modified with PLL were effective at adsorbing LPS in buffered
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solutions, however, the selective removal of LPS from solutions containing proteins was
not tested.

Common proteins tested for clearance with filtration membranes and

chromatographic columns include bovine serum albumin, lysozyme, insulin, myoglobin,
γ-Globulin, cytochrome c, and immunoglobulin G (1, 3, 8). While a membrane may be
very effective at removing LPS through either electrostatic or hydrophobic interactions,
these same interactions may cause proteins or cells to bind to the membrane surface. The
removal of certain proteins from solution may need to be accompanied by a solution pH
change, as may be the case in avoiding the adsorption acidic proteins, such as albumin.

Adsorption of LPS to outer surface
of hollow fiber membranes
Perhaps the most intriguing membrane studied in Chapter 4 was the PS-PEG
copolymer membrane that exhibited high surface water contact angle, a unique threelayer structure, and adsorbed LPS primarily at the outer wall of the membrane. It is
interesting to note that the high water contact angle differs from similar membranes in the
literature, where the addition of PS-PEG caused a decrease in surface water contact angle
(9). The addition of PS-PEG is used in that study to decrease water contact angle and
increase water flux through the membrane. Also, possible restructuring of a polymer
network in polydimethylsiloxane-PEG membranes under prolonged exposure to water,
causing the PEG chains to swell near the surface, has been investigated (10). While it
was theorized in this dissertation that PEG chains were sequestered in the matrix of the
membrane, restructuring of the polymer matrix in aqueous conditions can also be
investigated.
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Limiting LPS adsorption to the outer surface of the PS-PEG hollow fiber in
Chapter 4 may be a vital finding for future studies. It has been reported that LPS does
not need to be in direct contact with blood to elicit a pyrogenic response (11). Therefore,
it would be of interest to the hemodialysis community to attempt to limit LPS adsorption
to the outside of the polymer membrane. While PS-PEG was shown to be effective at
limiting adsorption of LPS as seen in Fig. 4.11, it did not limit back-filtration of LPS into
the blood compartment.
In Chapter 5 it was shown that small quantities of PLL on hollow fiber
membranes were effective at adsorbing large quantities of LPS, but adsorption occurred
throughout the fiber matrix with large quantities being found near the fiber lumen. The
method of preparing hollow fiber membranes is a well-defined process, dependent on the
thermodynamics of phase separation techniques (12-13). However, methods to prepare
membranes containing small amounts of PLL on the outer surface of the membrane may
prove beneficial in removing large quantities of LPS from solution, while encouraging
adsorption of LPS far from the lumen of the membrane (Fig 6.1).
Addition of PLL to the outside of the polymer membrane may be achieved during
the final testing stage of a hemodialyzer before packaging. Each dialyzer is tested for
leaks by pumping water through the dialysate compartment, while air is pumped through
the blood compartment. PLL at a low concentration could be mixed with the water to
coat the membranes. The amount of PLL deposited on the surface of each dialyzer would
need to be monitored to not exceed 0.67 µg/cm2 (maximum surface concentration of PLL
in the membranes modified using 1 µg/ml PLL in Chapter 5). Because of the porous
structure of the membranes, deposition of PLL (70-150 kDa) throughout the membrane
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may be considered uniform, except near the lumen where pores become much smaller
and PLL would be unable to pass.

FIG. 6.1. Schematic of cross section of hollow fiber membrane modified using
positively-charged PLL as a negatively-charged LPS adsorbent.

FIG. 6.2. Schematic of methods for imaging LPS with AFM. Method 1 involves tapping
mode AFM to view LPS aggregates. Method 2 employs a gold labeled anti-LPS
antibody. Method 3 employs an anti-LPS antibody and a labeled anti-antibody antibody.
Method 4 involves coating the AFM tip with anti-LPS antibody for use with tapping
mode AFM.
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Localization of LPS on HFM surfaces
Mapping LPS adsorption to membranes in this dissertation was achieved using
cryosectioning of HFMs and imaging with fluorescence microscopy. In this method,
HFMs are embedded in a freezing medium and sectioned using a sharp, Teflon-coated
blade. There has been concern in the literature that this method of sectioning may cause
“smearing” of LPS across the membrane surface (14). Due to the size scale used to
image membranes in this dissertation, “smearing” of LPS may be considered to be
negligible. However, “smearing” is likely of concern when locating LPS on the nanoscale. To image on this scale, membranes would likely need to be fractured in liquid
nitrogen and embedded such that adsorbed LPS is not disturbed.
Localizing LPS on HFMs on the nano-scale may require using new methods
beyond that of fluorescence microscopy. TOF-SIMS and AFM have both been utilized to
image cross-sections of polymer HFMs, however images produced were unclear (14-16).
We found that imaging the cross-section of polymer hollow fiber membranes proved
difficult due to the geometry of hollow fiber matrix. However, vague images of HFM
cross-sections were produced.
To facilitate the visualization of LPS adsorbed to HFM cross-sections, the use of
labeled antibodies may be employed. The use of gold-labeled antibodies may facilitate
LPS localization. Gold-labeled antibodies adsorbed directly to the LPS (Method 2, Fig.
6.2), or a method akin to sandwich ELISA (Method 3, Fig. 6.2), would provide a gold
signal which may be seen using either TEM or the phase signal of AFM. Anti-LPS
antibody may also be adsorbed to an AFM tip itself (17), causing stronger attraction of
the AFM tip to areas where LPS is adsorbed (Method 4, Fig. 6.2).
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APPENDIX A
This appendix presents data collected from flat sheet membranes made from a
polymer spin mass containing PS-PVP that were subjected to bleach treatment for various
times to determine the effect of bleach on water contact angle. Flat sheet membranes
were prepared similar to the casting technique used to prepare hollow fibers. Polymer
spin mass of the same content as that used to produce hollow fibers was dispensed on a
clean glass cover slip and spun at high revolution per second (3000 rpm) for 10 seconds.
While the polymer mixture was spinning, a coagulation fluid was dispensed thereon to
initiate phase inversion from wet phase to solid polymer membrane. Upon completion of
the spinning process, the membranes were removed from the glass, thoroughly rinsed
with water at 70oC, and placed in a drying oven overnight. Membranes were then
immersed in a bath containing 0.57% effective sodium hypochlorite content at 70oC for
varying amounts of time. Water contact angle was measured similar to the method
mentioned in Chapters 3 and 4, however, larger droplets of 1 µL were used (n = 9).
It was seen that longer bleaching times led to an increase in contact angle of both
the lumen and backside of the membranes. Water contact angle from 1 minute increased
dramatically, contrary to results reported in Chapters 3 and 4. This quicker reaction for
flat-sheet membranes may be due to the location and availability of PVP in the flat-sheet
geometry versus the hollow fiber geometry. As bleaching time increased to 30 minutes,
contact angles of flat-sheet membranes approached approximately 80o for both lumen and
backside. This corresponds to the contact angle for PS membranes as seen in Chapter 3.
Therefore, it can be inferred that bleaching of PS-PVP membranes removes PVP from the
membrane, leaving a membrane composed primarily of hydrophobic PS.
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FIG. A.1. Water contact angles of flat-sheet geometry PS-PVP membranes subjected to
0.57% bleach for varying amounts of time. “Lumen” represents the top side of the
membrane, equivalent to the lumen side of a hollow fiber membrane. “Backside”
represents the bottom side of the membrane, equivalent to the outside surface of a hollow
fiber membrane.
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APPENDIX B
Here are presented AFM and SEM images of the lumen and outside of hollow
fiber membranes examined in Chapter 4 including Optiflux®, bleached, high PVP, low
PVP, and copolymer membranes. AFM images were obtained similar to the process
described in Chapter 3. Briefly, membranes were sectioned using a stereo microscopy to
reveal the lumen surface, and rolled flat to present the outside surface of membrane as a
flat surface.

A Bioscope AFM was affixed with a silicon nitride cantilever and

membrane surfaces were scanned with a 2 x 2 µm2 scale for lumens and a 10 x 10 µm2
scale for outside surfaces. Root mean square roughness was performed and is presented
as mean ± standard deviation (n = 5). SEM images were obtained according to process
outlined in Chapter 4.
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FIG. B.1. AFM and SEM images of control (Optiflux®) membrane. (A) AFM of lumen
at 2 x 2 µm2 x 50 nm. (B) AFM of outside at 10 x 10 µm2 x 500 nm. (C) SEM of lumen
at 20000X. (D) SEM of outside at 5000X. AFM and SEM images reveals nodule
aggregates as described in Chapter 3 as well as porous outer membrane.
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FIG. B.2. AFM images of bleached membrane. (A) AFM of lumen at 2 x 2 µm2 x 50
nm. (B) AFM of outside at 10 x 10 µm2 x 500 nm. (C) SEM of lumen at 20000X. (D)
SEM of outside at 5000X. Nodule aggregates are smaller than those from the control
membrane, while pores on the outside are significantly larger than those of the control
membrane.
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FIG. B.3. AFM images of high PVP membrane. (A) AFM of lumen at 2 x 2 µm 2 x 50
nm. (B) AFM of outside at 10 x 10 µm2 x 500 nm. (C) SEM of lumen at 20000X. (D)
SEM of outside at 5000X. Membrane is very similar to the bleached membrane on the
outside, but the lumen exhibits a rougher surface comprised of small nodule aggregates.

127

FIG. B.4. AFM images of low PVP membrane. (A) AFM of lumen at 2 x 2 µm2 x 50
nm. (B) AFM of outside at 10 x 10 µm2 x 500 nm. (C) SEM of lumen at 20000X. (D)
SEM of outside at 5000X. Membrane is similar to bleached and high PVP membrane on
both lumen and outside surfaces.
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FIG. B.5. AFM images of PS-PEG copolymer membrane. (A) AFM of lumen at 2 x 2
µm2 x 50 nm. (B) AFM of outside at 10 x 10 µm2 x 500 nm. (C) SEM of lumen at
20000X. (D) SEM of outside at 5000X. Lumen surface is similar to PS-PVP membranes
with small nodule aggregates, but the outside surface is more similar to the control
membrane, containing smaller pores.
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Table B.1. RMS roughness values for lumen side and outside of membranes (mean ±
s.d., n = 5). Lumen side imaged at 2 x 2 μm2 and outside imaged at 10 x 10 μm2.

Fiber Type
Control
Bleach
High-PVP
Low-PVP
Copolymer

Lumen Side
19.7 ± 0.9
20.8 ± 6.0
25.2 ± 7.1
18.6 ± 11.1
13.4 ± 3.1

Outside
38.6 ± 15.2
105.7 ± 30.1
148.5 ± 45.1
85.5 ± 40.9
116.1 ± 63.6

Statistical analysis of RMS values showed significant difference between control
and copolymer membranes on the lumen side and significantly larger values for bleach,
high-PVP, and copolymer membranes compared to the control membrane on the outside.
Outside morphologies show smaller pores for the control and copolymer membranes
compared to the other membranes. It is interesting to note the differences and similarities
of the control and copolymer membranes.

While they exhibited similar outside

membrane structure, the copolymer membranes had a significantly larger surface
roughness. Also, the smaller nodule aggregates lowered overall roughness, but did not
cause retention or adsorption of LPS as seen in fluorescence images presented in Chapter
4.

The bleached, high PVP, and low PVP membranes all exhibited similar AFM

morphologies, yet drastically different adsorptions of LPS indicating that chemical
differences may not cause dramatic morphological changes, but do alter adsorption
capacities.
SEM images reveal that the high PVP membrane had a much more porous lumen
structure compared to all other membranes.

Outside morphologies reveal that the

copolymer and low PVP membranes were much less porous, with pores on the copolymer
membrane being much smaller than those of all other membranes.
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APPENDIX C
SEIVING COEFFICIENTS OF POLYMER HOLLOW FIBERS FROM
CHAPTER 4

FIG. C.1. Sieving coefficients of polymer hollow fibers. All hollow fibers effectively
limit molecular weight transfer below approximately 5% at 60 kDa, except the copolymer
membrane. This membrane may have undergone a physical breach allowing transfer of
higher molecular weight species.
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APPENDIX D
This appendix includes fluorescence images of polymer hollow fibers modified
with PLL and challenged with fluorescent-labeled LPS as shown in Chapter 5. Patterns
of fluorescence described in Fig. 5.8 are shown in Fig. D.1.

FIG. D.1. Fluorescence images of polymer hollow fiber modified with PLL at various
concentrations and challenged with 0.1 µg/ml fluorescent-labeled LPS. Images (A)-(F)
represent fibers modified with PLL using no cross-linking agent, whereas images (G)-(L)
represent fibers modified with PLL and cross-linked using GA.
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APPENDIX E
Included in this appendix are AFM images of LPS and PLL on mica as described
in Chapter 5. Also included are line cuts used to measure height and width features of
LPS “islands” seen in AFM images of mica touched to the air-water interface of LPS
solutions. Images of LPS and PLL on mica show similar trends seen in Chapter 5 with a
more organized structure associated with higher concentrations of PLL in LPS. Upon
reaching a PLL to LPS ratio of 1:1, a film layer formed on the mica similar in structure to
that seen in Panel C of Fig. 5.6.
Line cuts similar to those found in Fig. E.2 were used to calculate height values of
features seen in AFM images, as mentioned in Chapter 5. As the concentration of LPS
increased in solution, features on the mica surface grew both in height and diameter.

FIG. E.1. AFM images of LPS and PLL on mica from solutions containing 47.5 μg/ml
LPS and (A) 0.5 μg/ml PLL, (B) 5 μg/ml PLL, and (C) 50 μg/ml PLL. A film layer of
LPS and PLL formed on the mica starting at a concentration of 50 µg/ml PLL.
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FIG. E.2. AFM images of LPS on mica from solutions containing (A) 1 μg/ml, (B) 10
μg/ml, (C) 50 μg/ml, and (D) 100 μg/ml LPS in PBS, and subsequently profile cuts using
Nanoscope III Imaging Software. Solutions containing more than 10 μg/ml LPS led to
images containing small “islands”, presumably LPS deposits on the mica surface.
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